Global Type 1 SBS-IF (Intestinal Failure) 처리 시장 크기, 공유 및 동향 분석 보고서 – 산업 개요 및 예측 2033

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Type 1 Sbs If Short Bowel Syndrome With Intestinal Failure Treatment Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 무료 샘플 보고서 무료 샘플 보고서 구매하기 전에 문의 구매하기 전에 문의 지금 구매 지금 구매

Global Type 1 SBS-IF (Intestinal Failure) 처리 시장 크기, 공유 및 동향 분석 보고서 – 산업 개요 및 예측 2033

글로벌 스페셜티 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel Syndrome) 처리 시장, 처리 Modcy (Nutritional Support Therapy, Pharmacological Therapy, Surgical & Interventional Treatment, Emerging & Advanced Therapies), Market Attribution (Core SBS-IF Market, SBS-IF Attributable Market, Adjacent / Non-Specific Market), 질병 관리 단계 (Acute Phase), 임상 시험 및 임상 시험 (Acute Phase), 임상 시험 (Acute Phase) 및 임상 시험 (Acute Training Center)

  • Healthcare
  • Jun 2026
  • Global
  • 350 Pages
  • 테이블 수: 2763
  • 그림 수: 38
지금 구매 지금 구매 샘플요청 샘플요청
Nucleus Nucleus

Global Type 1 Sbs If Short Bowel Syndrome With Intestinal Failure Treatment Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Chart Image USD 1.02 Billion USD 1.71 Billion 2025 2033
Diagram 예측 기간
 2026 –2033
Diagram 시장 규모(기준 연도)
 USD 1.02 Billion
Diagram 시장 규모(예측 연도)
 USD 1.71 Billion
Diagram 연평균 성장률
 %
Diagram 주요 시장 플레이어
  • Takeda Pharmaceutical Company Limited (일본)
  • Fresenius Kabi AG (독일)
  • Baxter International Inc. (미국)
  • Nestlé 건강 과학 (스위스)
  • Abbott Laboratories (미국)

글로벌 스페셜티 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel Syndrome) 처리 시장, 처리 Modcy (Nutritional Support Therapy, Pharmacological Therapy, Surgical & Interventional Treatment, Emerging & Advanced Therapies), Market Attribution (Core SBS-IF Market, SBS-IF Attributable Market, Adjacent / Non-Specific Market), 질병 관리 단계 (Acute Phase), 임상 시험 및 임상 시험 (Acute Phase), 임상 시험 (Acute Phase) 및 임상 시험 (Acute Training Center)

유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장크기 (mm)

Type 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장 크기는 평가되었습니다100억 달러견적 요청100억 달러 2033, 에 a7.3%의 CAGR예측 기간 중. 시장은 짧은 장 증후군의 증가로 인해 꾸준한 성장을 목격하고 희귀 위장 장애에 대한 인식과 전문 영양 및 약리학 치료의 지속적인 발전에 대한 인식을 얻고 있습니다. 다중화 치료 접근의 성장 채택은, 개량한 진단 기능 및 강화된 환자 관리 전략과 결합해, 시장 확장을 지원하는 더입니다.

Crohn의 질병, mesenteric ischemia, 외상, congenital 이상과 같은 조건에서 발생되는 장막의 증가된 짐은 유형 1 SBS-IF 처리를 위한 수요에 크게 공헌했습니다. 건강 관리 제공자는 더 많은 부모 영양, enteral 영양 지원 및 포도상 같이 펩티드 2 (GLP-2)를 사용하여 장 적응을 개량하는 아날로그 치료, 합병증을 감소시키고, 생활의 참을성 있는 질을 강화합니다.

주요 시장 동향 &분석

  • 북미는 1 SBS-IF (Intestinal Failure) 치료 시장과 고급 의료 인프라, 강력한 재투자 정책에 의해 지원되는 2025 년에 41.37%의 가장 큰 수익 점유율을 가진 유형 1 SBS-IF (Short Bowel Syndrome를 지배하고, 장 재활 센터를 전문화하는 넓은 접근을 지배했습니다.
  • 영양 지원 치료 세그먼트는 2025 년에 41.93% 점유율을 가진 시장을, 장 회복 도중 수화, 양분 흡수 및 전반적인 환자 관리 유지에 있는 그것의 중요한 역할에 의해 모는 지도했습니다.
  • Asia-Pacific은 2026년부터 2033년까지 8.0%의 CAGR에서 가장 빠르게 성장하는 지역이 될 것으로 예상되며, 의료적 접근성 향상, 희귀 위장 장애의 인식 증가, 신흥 경제학의 고급 치료 옵션에 대한 투자 증가.
  • Emerging and Advanced Therapies는 7.7%의 CAGR를 등록하기 위해 계획된 가장 빠르게 성장하는 치료 형태입니다, 혁신적인 생물 공학, GLP-2 아날로그의 증가 채택을 반영하고, 장기적인 보호자 영양 의존을 감소시키는 것을 목표로 하는 재생 치료 접근.
  • 핵심 SBS-IF 시장 세그먼트는 2025년에 56.73%의 수익 공유를 가진 시장 attribution 종류를, 전문화하고 지속적인 장 실패 관리를 요구하는 실질적인 참을성 있는 인구에 의해 지원했습니다.
  • 급성 단계 (유형 1 SBS-IF) 세그먼트는 2025 년 48.47%의 가장 큰 점유율을 차지하고, 집중적인 영양 지원, 유체 관리 및 주요 장막 또는 부상을 따르는 임상 개입에 대한 즉각적인 필요성을 기반으로합니다.
  • 적응 단계는 가장 빠르게 성장하는 단계 범주가 될 것으로 예상되며, 예측 기간 동안 7.6%의 CAGR을 등록하고, 장 적응을 강화하고 영양 흡수를 향상시키고 장기 환자 회복을 지원합니다.

Type 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment MarketType 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment Market

시장 크기 & Forecast

  • 글로벌 시장 가치 (2025) : USD 1.12 억
  • 예상 시장 가치 (2033): USD 1.71 억
  • 캐스트 CAGR (2026–2033): 7.3%
  • 2025년에 지도하는 지역: 북아메리카
  • 가장 빠른 성장 지역: Asia-Pacific

Type 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment Market

보고서 범위 및유형 1 SBS-IF 처리 시장 세그먼트

관련 기사

유형 1 SBS-IF 처리 열쇠시장 통찰력

Segments 적용
  • 처리 Modality에 의하여:영양 지원 치료, 약리학 치료, 외과 및 개입 치료 및 Emerging & Advanced Therapies
  • 시장의 특성:핵심 SBS-IF 시장, SBS-IF Attributable 시장 및 Adjacent/Non-Specific 시장
  • 질병 관리 단계:급성 단계 (유형 1 SBS-IF), 적응 단계 및 회복 단계
  • 환자 유형: 성인과 소아과
  • 행정구역:Intravenous, Subcutaneous, 구두, 및 Enteral
  • 정맥 유형에 의하여:PN 및 주사
  • 최종 사용자:병원(Acute Care), Home Care(HPN Programs), ICU Settings, Specialty GI Center 및 소아과 전문병원
  • 배급 채널에 의하여:병원 약국, 전문 약국, 소매 약국 및 온라인 약국

국가 덮음

북아메리카

· 미국

· 캐나다

· 멕시코

·

· 독일

· 프랑스

· 미국

· 네덜란드

· 스위스

· 벨기에

· 러시아

· 이탈리아

· 스페인

· 터키

· 유럽의 나머지

아시아 태평양

· 중국

· 일본

· 인도

· 대한민국

· 싱가포르

· 말레이시아

· 호주

· 태국

· 인도네시아

· 필리핀

· 아시아 태평양의 휴식

중동 및 아프리카

· 사우디 아라비아

· 미국

· 남아프리카 공화국

· 이집트

· 이스라엘

· 중동 및 아프리카의 나머지

대한민국

· 브라질

· 아르헨티나

· 남미의 휴식

핵심 시장 선수

· Takeda Pharmaceutical Company Limited (일본)

· Fresenius Kabi AG (독일)

· Baxter International Inc. (미국)

· Nestlé 건강 과학 (스위스)

· Abbott Laboratories (미국)

· 뉴질랜드 Pharma A/S (덴마크)

· 한미제약 (주)코스메틱

· OxThera (스웨덴)

· AmeriPharma 전문 케어 (미국)

· ContinuumRx (미국)

· Napo 치료 (스위스)

· Eclipse Regenesis (미국)

· AcuLife Healthcare Private Limited (인도)

· 페링 제약 (스위스)

· 산동 Qidu 약제 Co., 주식 회사 (중국)

· 선택 육아 영양 LLC (미국)

· 통합 관리 시스템 (U.S.)

· 베벌리 힐스 소화 관리 (미국)

· Stanford 건강 관리 (미국)

· Vision Parenteral (미국)

· Amsino International, Inc. (미국)

· Aculife 건강 관리 (인도)

· Nutrego (네덜란드)

· Camvitaa (인도)

· Laboratoire Dielen (프랑스)

· Infusion Solutions (미국)

· 오로라 헬스케어 (미국)

시장 기회

· 재생 의학의 발전

· 홈 기반 영양 관리의 확장

Value 추가 데이터 Infosets

시장 가치, 성장률, 세그먼트, 지리적 범위 및 주요 플레이어와 같은 시장 시나리오에 대한 통찰력 외에도 데이터 브리지 시장 연구에 의해 큐레이터 시장 보고서는 심층적 인 전문가 분석, 환자 분석, 파이프라인 분석, 가격 분석 및 규제 프레임 워크를 포함합니다.

유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 동향

동향: 복잡한 다중화 환자 관리

재생 의약품 및 내장 재활의 발전은 글로벌 유형 1 SBS-IF 치료 시장의 강력한 성장 기회를 창출하고 있습니다. 연구자 및 의료 기관은 더 많은 치료에 초점을 맞추고, 손상된 장 조직을 재생하고, 부모 영양에 장기 의존을 감소시킵니다. 국립 보건 연구소 (National Institute of Health)에서 지원하는 연구에 따르면 줄기 세포 치료, 조직 공학 및 장식 이식 연구와 같은 재생 된 접근법은 심각한 SBS-IF 환자의 영양 흡수 및 회복 활 기능을 개선하는 결과를 보여주고 있습니다. 북미 및 유럽의 여러 학술 병원 및 전문 장 재활 센터는 GLP-2 치료, 고급 영양 지원, 수술 및 개인화 재활 계획을 결합하는 다국적 치료 프로그램을 확장하고 있습니다. 이러한 개발은 환자 생존과 삶의 질을 개선하고 기존 영양 관리보다 새로운 장기 치료 기회를 열어줍니다.

유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 역학

주요 시장 드라이버: SBS-If 환자 인구 상승

Intestinal Failure (SBS-IF)와 Short Bowel Syndrome에서 고통받는 환자 인구는 글로벌 치료 시장을위한 주요 성장 드라이버 중 하나입니다. SBS-IF는 주로 작은 장의 큰 부분이 수술을 통해 제거 될 때 개발, 영양분과 유체를 흡수하는 신체의 능력을 감소. 당뇨병 및 소화 및 신장 질환 (NIDDK)의 국립 연구소에 따르면, Crohn의 질병, 장암, 외상, 장 병, ischemia 및 장막 장애와 같은 질병을 위해 수행 한 작은 장막 수술 후 가장 일반적으로 발생합니다. 염증성 장 질환의 성장의 원인, 특히 Crohn의 질병은 전 세계적으로 장 수술의 증가에 크게 기여하고 있습니다. NIDDK는 또한 심각한 Crohn의 질병 환자가 종종 SBS-IF 개발의 장기적인 위험을 올릴 수 있는 반복적인 창구를 요구합니다.

중요한 Restraint/Challenge: 처리가 SBS 경우에 높은 비용

SBS-IF 치료의 높은 비용은 글로벌 유형 1 SBS-IF 치료 시장의 가장 큰 억제 중 하나입니다. Intestinal 실패를 가진 짧은 Bowel 증후군을 가진 환자는 수시로 일생 보호자 영양, 빈번한 병원 감시, 전문화한 장 재활 및 teduglutide와 같은 진보된 생물 논리 치료를 요구합니다. 미국 식품 및 의약품 관리 및 다케다 치료 정보에 따르면 GATTEX와 같은 GLP-2 치료는 미국 환자 당 거의 USD 400,000-USD 500,000을 요할 수 있으며 많은 가족 및 의료 시스템에 대해 재정적으로 어려운 치료를합니다. 약 비용 외에도 SBS-IF 환자는 종종 중앙 정맥 카테테르 관리, 영양 보충제, 일반 혈액 검사 및 감염 또는 탈수 합병증으로 인한 반복 된 병원 입학이 필요합니다. 이 장기 의료비는 환자와 보험 제공자 모두에 대한 주요 부담을 배치, 특히 드물게 질병에 대한 퇴거 적용은 여전히 제한됩니다.

주요 시장 기회: 진보된 생물학 및 GLP-2 아날로그 치료의 확장.

글로벌 유형 1 SBS-IF 치료 시장은 치료 및 영양 관리 접근법의 지속적인 발전에 의해 구동되는 상당한 성장 기회를 제공합니다. 혁신적인 생물 공학의 채택을 증가, 특히 GLP-2 아날로그 치료, 장 적응을 개선하고 부모 영양에 의존을 감소시키기 위해 새로운 정맥을 만드는. 개인화 된 영양 계획과 다발적인 배려에 대한 성장 초점은 환자의 결과 및 확장 치료 접근성을 강화하고 있습니다. Emerging economies는 의료 인프라 개선, 희귀 위장 장애의 더 큰 인식, 그리고 의료 지출 상승에 실질적인 잠재력을 제공합니다. 또한, 재생 의학의 지속적인 연구, 줄기 세포 근거한 치료 및 장 조직 기술설계는 미래 처리 paradigms를 변형할지도 모릅니다. 홈 기반 관리 모델 및 원격 모니터링 솔루션 확장은 장기적인 질병 관리 및 환자의 삶의 질을 개선할 것으로 예상됩니다.

Type 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment Market

유형 1 SBS-IF 처리 시장 범위

Type 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 처리 modality, 시장 attribution, 질병 관리 단계, 환자 유형, 관리의 노선, 최종 사용자, 배급 수로에 근거를 둔 주목할만한 세그먼트로 분할됩니다.

  • 치료 modality

치료 형태에, 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 치료 시장은 영양 지원 치료, 약리학 치료, 외과 및 개입 치료 및 신흥 및 고급 치료로 구분됩니다. 2026년에 영양 지원 치료 세그먼트는 영양 재활에 유형 1 SBS-IF 환자의 중요한 의존 때문에 42.00%의 점유율을 가진 시장을 지배할 것으로 예상되고 장기 장은 수화, 양분 흡수 및 전반적인 대사 안정성 유지를 위한 치료를 지원합니다

Emerging & Advanced Therapies 세그먼트는 혁신적인 위장 치료, 재생 의학 및 장내 실패 (SBS-IF)를 가진 짧은 장군 증후군을 위한 펩타이드 근거한 치료에 집중된 연구와 개발 활동을 증가시켜서 7.7%의 가장 빠른 CAGR를 목격하기 위하여 예상됩니다. 고급 생물 공학의 성장 채택, 임상 시험 투자 상승, 및 장기 보호자 영양에 의존을 감소 치료에 대한 증가 수요는 개발 및 신흥 의료 시장에서이 부문의 성장을 가속화하고있다.

  • 으로 Market attribution

시장에서 attribution의 기초에, 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장은 핵심 SBS-IF 시장, SBS-IF attributable 시장 및 인접한/비 특정 시장으로 구분됩니다. 2026년에, 핵심 SBS-IF 시장 세그먼트는 SBS-IF 관리와 직접 관련된 표적 개질 처리에 전문화된 영양 치료에 높은 임상 의존 때문에 56.72%를 가진 시장을 지배할 것으로 예상됩니다.

SBS-IF attributable 시장 세그먼트는 2026년에서 2033년까지 9.5%의 가장 빠른 CAGR를 목격할 것으로 예상되고, 짧은 장 증후군 관련 장 실패 및 장기 영양 및 위장 지원 치료에 대한 상승 수요가 증가합니다. 성장은 육아 영양 정립에 있는 발전에 의해 더 지원되고, 표적 치료의 가용성을 확장하고, 조기 진단과 전문화한 처리 접근에 대하여 인식을 성장하는 것은 생활의 참을성 있는 질을 개량하고 병원화 비율을 감소시키기를 목적으로 합니다.

  • 질병 관리 단계

질병 관리 단계의 기초에, 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장은 급성 단계 (유형 1 SBS-IF), 적응 단계 및 회복 단계로 구분됩니다. 2026년에 급성 단계 (유형 1 SBS-IF) 세그먼트는 집중적인 영양 지원, 유동성 안정화 및 장막 발기부전 또는 외과 재구성을 위한 즉시 필요조건 때문에 48.46%의 점유율을 가진 시장을 지배할 것으로 예상됩니다.

적응 단계는 2026에서 2033에 7.6%의 가장 빠른 CAGR를 목격하는 것으로 예상되며, 장 재활 치료 요법과 고급 영양 관리 전략에 초점을 맞추고 장부 영양에 장기적인 의존도를 줄입니다. 개인화 된 치료 접근의 상승 채택, 초기 개입에 대한 임상 인식 성장, 위장 치료의 지속적인 발전은 예측 기간 동안이 부문의 급속한 성장을 지원하는 것입니다.

  • 관리 방법

행정 경로의 기초에, 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 치료 시장은 정맥, 피임약, 경구 및 enteral로 구분됩니다. Intravenous 세그먼트는 PN 및 주사제로 더 구분됩니다. 2026년에, 정맥 세그먼트는 49.45%의 몫을 가진 시장을 지배할 것으로 예상됩니다 모체 영양의 광범위하게 이용 및 타협한 장 흡수 수용량을 가진 긴요한 ill SBS-IF 환자에 있는 병원 배드 치료.

subcutaneous 세그먼트는 최소 침략 약물 관리 방법 및 유형 1 SBS-IF 환자 중 가정 기반 치료 솔루션의 성장 채택을 위해 최소한의 침략적 인 약 관리 방법에 대한 선호도에 의해 연료 2026에서 2033 %의 가장 빠른 CAGR을 목격 할 것으로 예상됩니다. 또한, 피임약 납품 정립에 있는 전진은, 환자 편익을 개량하고, 병원 방문을 감소시키고, 장기 지지 치료 치료 치료를 위한 상승 수요는 예측 기간 도중 이 세그먼트의 성장을 더 가속하고 있습니다.

  • 최종 사용자

최종 사용자의 기초에, 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 병원 (수성 배려), 가정 배려 (HPN 프로그램), ICU 조정, 특기 GI 센터 및 소아과 스페셜 병원으로 구분됩니다. 2026 년 병원 (수성 배려) 세그먼트는 38.67%의 점유율을 가진 시장을 지배할 것으로 예상됩니다 다중화 치료 관리, 집중적인 영양 감시, 및 SBS-IF 처리의 급성 단계 도중 전문화된 위장 배려를 위한 높은 필요조건 때문에.

홈 케어 (HPN 프로그램) 세그먼트는 장기적인 영양 지원을 필요로하는 환자 중 가정 기반 의료 솔루션에 대한 선호도가 증가하여 2026에서 2033 %의 가장 빠른 CAGR를 목격 할 것으로 예상됩니다. 환자의 편안함과 삶의 질 향상에 중점을 둔 의료 비용, 휴대용 주입 기술에 대한 진보는 전 세계적으로 가정 부모 영양 (HPN) 프로그램의 채택을 가속화하고 있습니다.

  • 유통 채널

배급 수로의 기초에, 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 치료 시장은 병원 약국, 전문 약국, 소매 약국 및 온라인 약국으로 구분됩니다. 2026 년에 병원 약국 부문은 46.37%의 점유율을 가진 시장을 지배할 것으로 예상됩니다. 간접 영양 치료, 생물 공학 및 SBS-IF 관리를위한 병원 설정 내에서 관리되는 주사 가능한 약물.

전문 약국 세그먼트는 2026 년에서 2033 년 7 %의 가장 빠른 CAGR를 목격 할 것으로 예상되며 개인화 된 치료 관리, 가정 기반 주입 서비스 및 유형 1 SBS-IF에서 고통받는 환자를위한 장기 영양 지원 치료가 증가합니다. 또한, 효율적인 약물 배포, 환자 모니터링, reimbursement 지원을위한 전문 약국 서비스의 성장 채택, 복잡한 치료 요법에 대한 향상된 준수는 예측 기간 동안 세그먼트 성장을 가속화하는 것입니다.

Type 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment Market

유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 지역 분석

북미는 유형 1 SBS-IF 치료 시장을 지배하고 고급 의료 인프라에 의해 지원되는 2025 년 41.37%의 가장 큰 수익 점유율을 차지하고, 호의를 베푸는 재투자 프레임 워크를 선호하고, 전문화된 장 재활 센터의 강한 존재. 짧은 활 증후군의 높은 인식과 초기 진단에서 지역 이익, 육아 영양 및 고급 약리학 치료의 광범위한 채택, 희귀 질환 연구에 상당한 투자. 또한, 혁신적인 생물학 치료, 강력한 임상 시험 활동의 가용성, orphan 약을 위한 강한 규제 지원은 시장 성장에 기여했습니다. 환자의 결과 개선에 중점을두고 장 실패와 관련된 장기 합병을 감소시키고 다발적 인 치료 프로그램에 대한 액세스를 확장하는 것은 글로벌 유형 1 SBS-IF 치료 시장에서 북미의 선도적 인 위치를 강화하는 것을 계속합니다.

Type 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Treatment Market

미국 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

미국 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 진보된 의료 시설, 강한 reimbursement 적용 및 전문화한 개화 프로그램의 광대한 가용성에 의해 모는 북아메리카 시장의 가장 큰 몫을 대표합니다. 육아 영양, 혁신적인 GLP-2 치료의 채택을 증가시키고, 지속적인 희귀 질환 연구 이니셔티브는 시장 성장을 지원하고 환자의 결과를 개선하는 것을 계속합니다.

유럽 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

유럽 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 잘 설립된 의료 시스템에 의해 구동되는 꾸준한 성장을 경험하고, 희소한 위장 장애의 인식을 증가시키고, 전문화한 장 재활 서비스의 광대한 가용성. 진보된 영양 지원 치료, 호의를 베푸는 orphan 약 정책의 성장 채택, 및 지속적인 임상 연구 활동은 지역을 통하여 처리 혁신을 지원하고 환자 결과를 개량합니다.

U.K. 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

미국 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 전문화한 영양 치료의 채택을 증가하고, 다발성 개화 서비스에 접근을 성장하는 잘 설치된 의료 시스템에 의해 지원됩니다. 희귀 위장 장애, 호의를 베푸는 임상 가이드라인의 인식과 생물학 치료의 지속적인 발전은 전국의 환자 관리 및 시장 성장을 개선하기 위해 기여하고 있습니다.

독일 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

독일은 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel Syndrome) 처리를 위한 뜻깊은 시장을 대표합니다, 그것의 진보된 건강 관리 체계, 강한 reimbursement 적용 및 전문화한 gastroenterology 및 장 재활 센터의 잘 설치한 네트워크. 육아 영양의 채택을 증가, 혁신적인 치료에 대한 액세스 성장, 지속적인 임상 연구 활동은 증가 환자 관리 및 전국 시장 성장에 기여.

아시아 태평양 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

아시아 태평양 유형 1 SBS-IF 치료 시장은 예측 기간 동안 CAGR에 등록하는 가장 빠른 성장을 목격 할 것으로 예상됩니다. 성장은 의료 인프라 개선에 의해 구동, 희귀 위장 장애의 인식 증가, 전문 영양 치료에 대한 액세스를 확장, 의료 지출 상승. 중국, 일본, 인도 및 대한민국과 같은 국가는 선진 치료 옵션 및 장 재활 서비스, 지역 전체에 시장 확장을 지원에 투자하고 있습니다.

일본 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

일본 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장은 국가의 진보된 건강 관리 체계 때문에 꾸준한 성장을 목격하고, 장막을 요구하는 위장 장애의 전세를 증가시키고, 희소한 질병 관리에 강한 초점. 전문 영양 지원 치료의 성장 채택, 혁신적인 치료에 대한 향상된 액세스, 장 재활 프로그램을 확장하는 것은 환자 관리 및 시장 개발 강화에 기여하고 있습니다.

중국 유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장 통찰력

중국 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 건강 관리 인프라 개선에 의해 구동되는 꾸준한 성장을 경험하고, 희소한 위장 장애의 인식을 증가시키고, 전문화한 영양 지원 치료에 접근을 확장합니다. 첨단 의료에 투자, 장 재활 프로그램의 채택 성장, 및 향상된 진단 능력은 시장 개발 지원. 또한, 드문 질병 관리 및 의료 접근성을 강화하기위한 정부 노력은 혁신적인 SBS-IF 치료 접근의 채택에 대한 호의적인 조건을 만듭니다.

유형 1 SBS-IF 처리 시장 점유율

유형 1 SBS-IF 처리 기업은 주로 다음을 포함하는 잘 설치된 회사에 의해 지도했습니다:

  • Takeda Pharmaceutical Company Limited (일본)
  • Fresenius Kabi AG (독일)
  • Baxter International Inc. (미국)
  • Nestlé 건강 과학 (스위스)
  • Abbott Laboratories (미국)
  • 뉴질랜드 Pharma A/S (덴마크)
  • 한미제약 (주)코스메틱
  • OxThera (스웨덴)
  • AmeriPharma 전문 케어 (미국)
  • ContinuumRx (미국)
  • Napo 치료 (스위스)
  • Eclipse Regenesis (미국)
  • AcuLife Healthcare Private Limited (인도)
  • 페링 제약 (스위스)
  • 산동 Qidu 약제 Co., 주식 회사 (중국)
  • 선택 육아 영양 LLC (미국)
  • 통합 관리 시스템 (미국)
  • 베벌리 힐스 소화 관리 (미국)
  • Stanford 건강 관리 (미국)
  • 비전 학부모 (미국)
  • Amsino International, Inc. (미국)
  • Aculife 의료 (인도)
  • Nutrego (네덜란드)
  • Camvitaa (인도)
  • Laboratoire Dielen (프랑스)
  • Infusion Solutions (미국)
  • 오로라 건강 관리 (미국)

Type 1 SBS-IF (Intestinal Failure) 치료 시장의 최신 개발

  • 2026 년 Takeda Pharmaceutical Company Limited는 생물 공학, 위장 혁신 및 고급 장 질환 치료 연구의 투자를 통해 위장 질병 및 희귀 장애 치료 포트폴리오를 확장하고 있으며 유형 1 SBS-IF (Intestinal Failure) 치료 시장의 장기적인 전략적 위치를 강화했습니다.
  • 2026 년 Abbott Laboratories는 고급 임상 영양 및 위장 관리 솔루션에 중점을두고 지속적인 혁신을 통해 영양 정립 및 병원 기반 영양 지원 치료, 유형 1 SBS-IF (Intestinal Failure) 치료 시장의 위치를 강화.
  • 3 월 2026에서 Nestlé Health Science는 혁신적인 의료 영양 솔루션을 도입했으며 임상 영양 및 위장 건강 포트폴리오를 확장하기 위해 영양 및 건강 과학 통합 전략을 강화하여 유형 1 SBS-IF (Intestinal Failure) 치료 시장의 성장 기회를 지원합니다. 2026, Unilever는 미국 기반의 보충 브랜드 Grüns의 인수를 발표하여 웰빙 및 건강 포트폴리오를 확장했습니다. 이 발달은 성장하는 nutraceutical와 cosmeceutical 세그먼트에 있는 Unilever의 위치를 강화합니다.
  • 4월 2026일, Baxter International은 AORN Global Surgical Conference & Expo 2026에서 최근 혁신을 선보였으며 영양 관리 및 연결 의료 기술 포트폴리오를 지속적으로 확장하여 중요한 관심과 SBS-IF 관련 치료 솔루션에 대한 존재를 강화했습니다.
  • 4월 2026일, Fresenius Kabi AG는 고급 의료 기술 및 생물 공학 치료 솔루션에 대한 지속적인 투자를 통해 임상 영양 및 주입 요법 포트폴리오를 확대하여 유형 1 SBS-IF (Intestinal Failure) 치료 시장의 위치를 강화했습니다.

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 소개

1.1 스튜디오의 활동

1.2 시장 결정

1.3 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME)의 개요

1.4 치료 및 포장

1.5 계약

1.6 시장 COVERED

2 시장 세그먼트

2.1 시장 덮개

2.2 GEOGRAPHICAL 가스

2.3 STUDY에 대한 년

2.4 DBMR 배드 자료 가변 모형

중요한 의견 지도를 가진 2.5 PRIMARY INTERVIEWS

2.6 DBMR 시장 위치

2.7 VENDOR 샤인 분석

2.8 MULTIVARIATE 모델

2.9 제품 유형 TIMELINE 구멍

2.1 시장 적용 커버리지 GRID

2.11 증권

2.12 소개

3 독점 요약

4 프리미엄 INSIGHTS

4.1 PESTEL 분석

4.1.1 소개

4.1.2 화학적 분석

4.1.3 ECONOMIC 분석

4.1.4 위생 분석

4.1.5 기술 분석

4.1.6 환경 분석

4.1.7 레갈 분석

4.1.8 계약

4.2 PORTER의 FIVE FORCES 분석

4.2.1 소개

4.2.2 적합성(HIGH)

4.2.3 구매자의 풍력 – 높은

4.2.4 새로운 범위의 THREAT – MODERATE

4.2.5 이하 제품의 THREAT – MODERATE

공급 장치의 4.2.6 BARGAINING 전력 - 모듈

4.2.7 규칙

4.3 회사 증발 수량

4.4 특허 FUNNEL METHODOLOGY (MANDATORY 모형)

4.4.1 BOTTOM-UP PATIENT FUNNEL는 통제될 것입니다

4.4.1.1 총 SBS POPULATION

4.4.1.2 SBS-IF 전시

4.4.1.3 DIAGNOSED SBS-IF 종이

4.4.1.4 TREATED SBS-IF 카드

4.4.1.5 THERAPY-SPECIFIC 구조

4.4.1.6 이 항목 번호는 시장 크기에서 INFERRED하지 않는, 완전히 ESTIMATED입니다

4.4.1.7 글로벌 특허 FUNNEL 세그먼트

4.4.1.8 TOTAL SBS 영상

4.4.1.9 축 SBS

4.4.1.10 체육 SBS

4.4.1.11 SBS-IF 전시

4.4.1.12 유형 1 SBS-IF (ACUTE)

4.4.1.13 유형 2 SBS-IF (냉각된 교류)

4.4.1.14 유형 3 SBS-IF (중앙)

4.4.1.15 DIAGNOSED 특허

4.4.1.16 DIAGNOSED – 병원 기반

4.4.1.17 DIAGNOSED – 외부 유출

4.4.1.18 UNDIAGNOSED/MISCLASSIFIED

4.4.1.19 보존 특허

4.4.1.20 활성 PATIENTS

4.4.1.21 / 지원

4.4.2 TREATMENT-SPECIFIC PATIENT 세그먼트 (CRITICAL)

4.4.2.1 PN-DEPENDENT 포장 (CORE SEGMENT)

4.4.2.2 풀 PN-DEPENDENT

4.4.2.3 부분적으로 PN-DEPENDENT

4.4.2.4 ICU PN-DEPENDENT (TYPE 1 ACUTE)

4.4.2.5 홈 PN-DEPENDENT

4.4.2.6 GLP-2 ANALOGUE는 특허를 받았습니다

4.4.2.7 INCLUDES 특허 등록 TEDUGLUTIDE

4.4.2.8 파이프 THERAPIES (E.G., APRAGLUTIDE)

4.4.2.9 이하 세그먼트

4.4.2.10 PN-DEPENDENT 저장 GLP-2

4.4.2.11 PN-WEANING 종이

4.4.2.12 PEDIATRIC 대 ADULT

4.4.2.13 지원 PHARMACOTHERAPY PATIENTS (ATTRIBUTABLE)

4.4.2.14 ANTI-DIARRHEAL 용도

4.4.2.15 PPI 사용자

4.4.2.16 분석 (SIBO) 특허

4.4.2.17 초동력 특허

4.4.2.18 연구 및 개발

4.4.2.19 INTESTINAL 엔진

4.4.2.20 TRANSPLANT 특허

4.4.2.21 POST-TRANSPLANT 나사

4.4.3 DEPENDENCY STATUS의 특허 세분화 (HIGHLY IMPORTANT)

4.4.3.1 PN-DEPENDENT 전시

4.4.3.2 핵심 REVENUE-DRIVING 세그먼트

4.4.3.3 PN-WEANING 포장

4.4.3.4 GLP-2 리포터

4.4.3.5 PN 소개

4.4.3.6 ORAL/ENTERAL 다른 사람에 MAINTAINED

4.4.4 오염 물질 (TYPE 1 FOCUS)

4.4.4.1 교류 PHASE (TYPE 1 SBS-IF)

4.4.4.2 ICU-MANAGED 종이

4.4.4.3 높은 PN 정비

4.4.4.4 고립 PHASE

4.4.4.5 엔터티 NUTRITION

4.4.4.6 GLP-2 기타의 취임

4.4.4.7 복구 / 복구

4.4.4.8 빨간 PN DEPENDENCY

4.4.4.9 롱 테라스

4.4.4.10 관리 세트에 의하여 특허가 주어진

4.4.4.11 병원 기초 PATIENTS

4.4.4.12의 ICU

4.4.4.13 농업용 용기

4.4.4.14 홈 케어 특허

4.4.4.15 홈 PARENTERALNUTRITION (HPN)

4.4.4.16 특별실

4.4.4.17 INTESTINAL 수리센터

4.4.5 DEMOGRAPHICS의 특허

4.4.5.1 AGE 그룹

4.4.5.2 이온

4.4.5.3 방어

4.4.5.4 의무

4.4.5.5 기타

4.4.5.6 제너레이터

4.4.5.7 남성

4.4.5.8 여성

4.4.6 ETIOLOGY의 특허

4.4.6.1 에어로빅

4.4.6.2 CROHN의 의무

4.4.6.3 메모리 ISCHEMIA

4.4.6.4 환경 조사

4.4.6.5 다운로드

4.4.6.6 PEDIATRIC 에너지

4.4.6.7 NECROTIZING ENTEROCOLITIS (NEC)

4.4.6.8 CONGENITAL DEFECTS (ATRESIA, GASTROSCHISIS)

4.4.7 GEOGRAPHIC 보호

4.4.7.1 북아메리카

4.4.7.2 미국

4.4.7.3 캐나다

4.4.7.4 유로

4.4.7.5 독일

4.4.7.6 프랑스

4.4.7.7 영국

4.4.7.8 이탈리아

4.4.7.9 스페인

4.4.7.10 아시아 수출

4.4.7.11 일본

4.4.7.12 중국

4.4.7.13 인도

4.4.8 치료 PENETRATION & UTILIZATION 비율

4.4.8.1 PN PENETRATION 날짜

PN에 SBS-IF PATIENTS의 4.4.8.2 %

4.4.8.3 GLP-2 PENETRATION 날짜

4.4.8.4 % ELIGIBLE PATIENTS RECEIVING GLP-2

4.4.8.5 지원 기타 PENETRATION

4.4.8.6 ANTI-DIARRHEAL 사용률

4.4.8.7 PPI 사용률

4.4.8.8 특허 COST 모델

4.4.8.9 PATIENT 당 ANNUAL COST

4.4.8.10 PN COST (HOSPITAL VS HOME)

4.4.8.11 GLP-2 기타 비용

4.4.8.12 지원 기타 비용

4.4.9 PATIENT 유형의 COST

4.4.9.1 특허

4.4.9.2 GLP-2 거래

4.4.9.3 트렁크

4.4.9.4 OUTPUT DELIVERABLES (EXCEL – CLIENT CRITICAL)

4.4.9.5 TOTAL SBS-IF PATIENTS (국가별)

4.4.9.6 DIAGNOSED VS 트렁크

4.4.9.7 PN-DEPENDENT 특허

4.4.9.8 GLP-2 뚜렷한 특허

4.4.9.9 거래 PENETRATION 날짜

4.4.9.10 다른 사람 당 평균

4.5 산업 INSIGHTS

4.5.1 소개

4.5.2 기업 구조 전망

4.5.3 MICRO와 MACRO 생태계

4.5.4 PENETRATION 및 성장 촉진

4.5.5 열쇠 담합 STRATEGIES

4.5.6 SPECIALISTS와 비교

4.5.7 분석 및 등록

4.5.8 조건

4.6 WAR-DRIVEN은 화학적 공급 업체, GEOGRAPHIC FOOTPRINTS, STRUCTURAL CHANGES 및 ADAPTIVE STRATEGIES에서 추출합니다.

4.6.1 소개

4.6.2 SUPPLY 사슬 탄력

4.6.2.1 INGREDIENT와 PN/DRUG SUPPLIERS의 의무

4.6.2.2 REGIONAL 생산 HUBS의 장비

4.6.2.3 CRITICAL PN BAGS, GLP-2 ANALOGUES 및 MEDICAL DEVICES의 STRATEGIC 추적

4.6.2.4 ALTERNATIVE LOGISTICS 및 COLD CHAIN ROUTES의 개발

4.6.2.5 CDMOS (E.G., CATALENT, LONZA)를 선도하는 STRATEGIC PARTNERSHIPS

4.6.2.6 PN 및 GLP-2를 위한 수동 포장 및 포장 장비의 제조

4.6.3 ENERGY & 수동 가동 위험

4.6.3.1 패터럴 NUTRITION & DRUG FACILITIES에 대한 에너지 절약

4.6.3.2 RAW 자료, LIPID EMULSIONS 및 물질에 대한 비용 절감

4.6.3.3 LONG-TERM ENERGY는 PN MANUFACTURERS를 위한 STRATEGIES를 실행합니다

4.6.3.4 에너지 효율적인 관리

4.6.3.5 보장된 자동화 및 지속적인 체계의 손상

4.6.3.6 MANUFACTURING FACILITIES의 새로운 에너지의 도입

4.6.4 GEOGRAPHIC 초점

4.6.4.1 STABLE REGIONS에 대한 관리

4.6.4.2 글로벌 PN/GLP-2 제품 사이트 구축

4.6.4.3 열쇠 INPUT/INTERMEDIATE 생산의 등록

4.6.4.4 높은 SBS-IF BURDEN를 가진 경쟁 시장

4.6.4.5 REGIONAL COLD CHAIN TRANSIT 및 DISTRIBUTION HUBS의 에너지

4.6.5 SCENARIO PLANNING & 위험 관리

4.6.5.1 자이언트 CONTINGENCY PLANS의 개발

4.6.5.2 MULTI-SOURCE PROCUREMENT STRATEGIES FOR PN/GLP-2

4.6.5.3 GOVERNMENT 및 건강 관리

4.6.5.4 CRITICAL THERAPIES를 위한 CRISIS-RESPONSE 공급 네트워크

4.6.5.5 SBS-IF 시장에 있는 예비 품목의 분해

4.6.6 CASH & 금융 보호

PN & BIOPHARMA EXPANSION를 위한 4.6.7 STRENGTHENING 수용량 예약

4.6.7.1 제품포트폴리오 및 REVENUE STREAMS의 의무

4.6.7.2 DOMESTIC PRODUCTION INFRASTRUCTURE에 대한 투자

4.6.7.3 GOVERNMENT INCENTIVES 및 PUBLIC-PRIVATE 파트너

4.6.7.4 LONG-TERM 관리 체계로 통제

4.6.8 DATA 보호

4.6.8.1 CLINICAL AND REAL-WORLD SBS-IF DATA에 대한 데이터 보호 FRAMEWORKS

4.6.8.2 CLINICAL TRIAL DATA, PATIENT DATA 및 DRUG DEVELOPMENT의 프로텍션

4.6.8.3 SBS-IF DATA 관리에 대한 보안 성능

4.6.8.4 시장 조사 및 PHARMA 네트워크에 있는 AI-DRIVEN THREAT 거래

4.6.8.5 PHARMACEUTICAL DATA 등록 및 GXP와 호환

4.6.9 새로운 사업과 EMERGING 책임 & 미래 발견

4.6.10 계약

4.7 EPIDEMIOLOGY의 특징

4.7.1 소개

4.7.2 유형의 기초 1 SBS-IF

4.7.3 거래 비율

4.7.4 순간 비율

4.7.5 치료 이점과 스위치 모형

4.7.6 특허 등록

4.7.7 계약

4.8 PHASE GLOBAL TYPE 1 SBS-IF MARKET의 제품 및 프로젝트의 배포

4.9 SCIENTIFIC APPROACH 및 PHASE의 프로젝트 배포 – GLOBAL TYPE 1 SBS-IF MARKET

4.1 THERAPEUTIC AREA 및 PHASE의 프로젝트의 배포 – GLOBAL TYPE 1 SBS-IF MARKET

4.11 파이프 ANALYSIS

4.11.1 소개

4.11.2 의학 TRIALS와 PHASE ANALYSIS

4.11.3 DRUG & BIOTHERAPY 파이프

4.11.4 PHASE III 카드 (E.G., APRAGLUTIDE)

4.11.5 PHASE II 카드 (E.G., LONG-ACTING GLP-2)

4.11.6 PHASE I 단말기 (EMERGING REGENERATIVE/CELLULAR)

4.11.7 기타 (공기, EN FORMULATION PIPELINE)

4.11.8 계약

4.12 파이프 분석

4.12.1 소개

4.12.2 TAKEDA PHARMACEUTICAL COMPANY – INTESTINAL REGENERATION THERAPIES의 R&D 리더쉽

4.12.3 BAXTER 국제 – PARENTERAL NUTRITION 및 INFUSION 시스템 혁신

4.12.4 FRESENIUS KABI AG – 의료용 영양 및 기타 식품

4.12.5 NESTLÉ 건강 과학 – MEDICAL NUTRITION AND GUT ADAPTATION RESEARCH

4.12.6 ABBOTT LABORATORIES – 통합 및 METABOLIC MONITORING 솔루션

4.12.7 계약

4.13 다른 분석

4.13.1 소개

4.13.2 드럭/기타

4.13.2.1 브랜드 이름

4.13.2.2 일반 이름

4.13.3 화학 분류

4.13.4 1차 산업

4.13.5 시장

4.13.6 MEDICATION 유형

4.13.7 복용량

4.13.8 평균 수명

4.13.9 포장 유형

4.13.10 행정의 ROUTE

4.13.11 두싱 주파수

4.13.12 기타 INSIGHT

4.13.13 DRUG DEVELOPMENT ACTIVITIES, 공장 MILESTONES, SAFETY/EFFICACY의 전망, 시장 우수한 자료

4.13.14 FORECAST 마켓

4.13.14.1크로스 COMPETITION

4.13.14.2 기타 PORTFOLIO

4.13.14.3 커런트 개발 SCENARIO

4.13.15 대회

4.14 파이프 분석 - GLOBAL TYPE 1 SBS-IF TREATMENT MARKET

4.14.1 의학 TRIALS와 PHASE ANALYSIS

4.14.2 DRUG 및 기타 파이프

4.14.3 PHASE III 카드

4.14.4 PHASE II 카드

4.14.5 PHASE I 기준

4.14.6 기타 (공기 및 재고 있음)

4.15 R & D 분석

4.15.1 완전한 분석

4.15.2 개발 LANDSCAPE

4.15.3 저장소에 INSIGHTS

4.15.4 기타 분류

4.15.5 ASSET-BASED 장비 및 부품

5 건강 관리 TARIFFS IMPACT 분석

5.1 전망

5.2 TARIFF 구조

5.2.1 글로벌 VS. REGIONAL TARIFF 구조

5.2.2 단위 체재: MEDICARE/MEDICAID TARIFF 지역

5.2.3 ASIA-PACIFIC: IMPORTED PN/DRUG THERAPIES에 GOVERNMENT TARIFFS

5.2.4 EMERGING 시장: NUTRITION & BIOLOGICS를 위한 TARIFF CHALLENGES

5.2.5 MAJOR 시장 UPTAKE

5.3 PHARMACEUTICAL TARIFFS 및 무역 BARRIERS

5.3.1 PN KITS, GLP-2 VS에 중요한 DUTIES. 일반

5.3.2 AFFORDABILITY 및 액세서리

5.3.3 열쇠 무역 AGREEMENTS AFFECTING SBS-IF 제품

PROVIDERS/PATIENTS에 대한 건강 관리의 5.4 IMPACT

5.4.1 비용 및 비용에 대한 비용

5.4.2 특허 및 인센티브

5.4.3 ADVANCED SBS-IF THERAPIES를 위한 MEDICAL TOURISM에 있는 폴란드

5.5 무역 및 건강 관리

5.5.1 WTO 재화

5.5.2 TRADE WARS 공급 차에 IMPACT

REDUCING TARIFFS에 있는 5.5.3 FTAS

5.6 건강 관리 비용 및 ACCESSIBILITY에 TARIFFS의 영향

5.7 HEALTHCARE SECTOR의 TARIFFS의 중요성

6 상표 부속품

6.1 10-YEAR 시장 예측

6.2 클린셜 리컬 UPDATES

6.3 SBS-IF TREATMENTS를 위한 새로운 FDA 승인

6.4 매뉴얼, DISTRIBUTORS 및 DEALS

6.5 MAJOR 시장 UPTAKE

6.6 CURRENT 거래 PRACTICES

6.7 IMPACT의 업그레이드

7 공장 FRAMEWORK–

7.1 소개

7.2 가구 APPROVAL PROCESS

7.3 GEOGRAPHIES의 액세서리 APPROVAL

7.4 지역 특허권

7.5 라이센스 및 등록

7.6 POST-마케팅 관리

7.7 좋은 관리 (GMPS) 가이드라인

7.8 계약

8 시장 전망

8.1 운전사

8.1.1 RISING SBS-IF 특허

8.1.2 GLP-2 THERAPIES의 접착

8.1.3 GOVERNMENT 및 ORPHAN DRUG 지원 제공

8.2 수익

8.2.1 SBS-IF 치료의 높은 비용

8.2.2 LIMITE.D AWARENESS & DELAYED DIAGNOSIS

8.3 기회

8.3.1 완전한 관리

8.3.2 수명 보증

8.4 도전

8.4.1 REGENERATIVE MEDICINE의 이점

8.4.2 가정 기초 배려의 전사

9 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TREATMENT MODALITY

9.1 전망

9.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

9.2.1 의무 지원

9.2.2 화학 물질

9.2.3 환경 & INTERVENTIONAL 치료

9.2.4 EMERGING & 광고 다른

9.3 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

9.3.1 특허법(PN)

9.3.2 환경 NUTRITION (EN)

9.3.3 PN 구성

9.4 GLOBAL PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.4.1 홈 관용 (HPN)

9.4.2 수직 방향 (PPN)

9.4.3 CYCLIC 주변 환경

9.5 GLOBAL TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.5.1 의학 기초 TPN

9.5.2 ICU 기초 TPN

9.6 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

9.6.1 모자 HPN

9.6.2 PEDIATRIC의 HPN

9.7 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TREATMENT DURATION, 2018-2033 (USD THOUSAND)

9.7.1 길이 HPN

9.7.2 SHORT 맨끝 HPN

9.8 GLOBAL ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.8.1 보통

9.8.2 관 패킹

9.8.3 FORMULA 유형

9.9 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.9.1 NASOGASTRIC (NG)

9.9.2 PEG 포장

9.9.3 JEJUNOSTOMY 매장

9.1 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.10.1 폴리에스테

9.10.2 관리

9.10.3 SEMI 장비

9.11 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME)에 있는 세계적인 PN 구성 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.11.1 맥론존

9.11.2 전기 & FLUIDS

9.11.3 미크론

9.12 유형 1 SBS-IF에 있는 세계적인 MACRONUTRIENTS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.12.1 아미노

9.12.2 레벨 EMULSIONS

9.12.3 덱스트로

9.13 유형 1 SBS-IF에 있는 세계적인 MICRONUTRIENTS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.13.1 비타민

9.13.2 트랙 엘리먼트

9.14 TYPE 1 SBS-IF (INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033, (USD THOUSAND)

9.14.1 북아메리카

9.14.2 유로

9.14.3 아시아 수출

9.14.4 MIDDLE 동쪽과 아프리카

9.14.5 사우스 캐롤라이나

9.15 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.15.1 HORMONAL & INTESTINAL 다른 사람

9.15.2 ANTI-DIARRHEAL 다른 사람

9.15.3 ANTI-SECRETORY 기타

9.15.4 중력 지원

9.15.5 ANTI-INFECTIVE 기타

9.15.6 BILE ACID 및 ABSORPTION 모듈

9.16 GLOBAL HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.16.1 GLP-2 카탈로그

9.16.2 성장 호르몬 다른

9.16.3 IGF-1 및 분석

9.17 유형 1 SBS-IF에 있는 세계적인 GLP-2 ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.17.1 테두리

9.17.2 APRAGLUTIDE (최신)

9.17.3 LONG-ACTING GLP-2 카탈로그

9.18 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 HORMONE 다른 사람) 무역 시장, SOMATROPIN-BASED에 의하여, 2018-2033 (USD THOUSAND)

9.18.1 허브

9.18.2 노르딕

9.18.3 제로핀

9.19 유형 1 SBS-IF에 있는 GLOBAL IGF-1 & ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.19.1 인치

9.19.2 기타

9.2 GLOBAL ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.20.1 OPIOID 기반

9.20.2 NON-OPIOID 발전기

9.21 글로벌 OPIOID-BASED TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.21.1 로비

9.21.2 코린

9.22 유형 1 SBS-IF에 있는 세계적인 ANTI-SECRETORY 다른 (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.22.1 PROTON 펌프 인젝터

9.22.2 SOMATOSTATIN 카탈로그

9.22.3 H2 수신기 ANTAGONISTS

9.23 유형 1 SBS-IF에 있는 GLOBAL PROTON PUMP INHIBITORS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.23.1 옴

9.23.2 팬텀

9.23.3 이소모프젤

9.23.4 기타

9.24 유형 1 SBS-IF에 있는 GLOBAL SOMATOSTATIN ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.24.1 캐럿

9.24.2 기타

9.25 GLOBAL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.25.1 FAMOTIDINE의

9.25.2 기타

9.26 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.26.1 FAT-SOLUBLE 비타민 (A, D, E, K)

9.26.2 전기

9.26.3 비타민 B12

9.26.4 중앙 지원

9.27 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)을 가진 GLOBAL ANTI-INFECTIVE THERAPY

9.27.1 블로드 SPECTRUM ANTIBIOTICS

9.27.2 SIBO-TARGETED 기타

9.28 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)을 가진 GLOBAL BILE ACID & ABSORPTION 형태

9.28.1 비어 있는 보조장치

9.28.2캐럿 ABSORPTION ENHANCERS

9.29 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

9.29.1 크리스마스

9.29.2 대학

9.29.3 기타

9.3 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME에 있는 세계적인 화학 물질 다른) 무역 시장, 2018-2033에 의하여, (USD THOUSAND)

9.30.1 북아메리카

9.30.2 유로

9.30.3 아시아 수출

9.30.4 중동과 아프리카

9.30.5 남쪽 AMERICA

9.31 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 대한 글로벌 연구 및 개발

9.31.1 INTESTINAL 선반설치

9.31.2 OSTOMY 및 등록

9.31.3 INTESTINAL 운송

9.32 GLOBAL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.32.1 STEP 완료

9.32.2 BIANCHI의 장점

9.33 GLOBAL OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.33.1 다운로드

9.33.2 제주도

9.33.3 REVERSAL 슈퍼

9.34 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.34.1 ISOLATED 폭

9.34.2 LIVER + 인테인

9.34.3 MULTIVISCERAL 운송

9.35 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

9.35.1 북아메리카

9.35.2 유로

9.35.3 아시아 수출

9.35.4 중동과 아프리카

9.35.5 SOUTH 아메리카

9.36 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

9.36.1 생식기

9.36.2 MICROBIOME 기초 다른

9.36.3 다른 사람

9.37 유형 1 SBS-IF에 있는 세계적인 기록적인 MEDICINE (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 유형, 2018-2033에 의하여 무역 시장,

9.37.1 줄기 세포 다른

9.37.2 TISSUE 엔진

9.38 유형 1 SBS-IF에 있는 세계적인 MICROBIOME 기초 다른 사람 (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

9.38.1 기술

9.38.2 FMT의 특징

9.39 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

9.39.1 ABSORPTIVE 기능 조정

9.39.2 MUCOSAL 지구 형태

9.4 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

9.40.1 북아메리카

9.40.2 유로

9.40.3 아시아 수출

9.40.4 중동 및 아프리카

9.40.5 사우스 캐롤라이나

10 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 SHORT BOWEL SYNDROME) 트레이싱 마켓, 마켓

10.1 전망

10.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

10.2.1 핵심 SBS-IF 시장

10.2.2 SBS-IF ATTRIBUTABLE 시장

10.2.3 ADJACENT/NON-SPECIFIC 시장

10.3 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

10.3.1 영주권

10.3.2 GLP-2 카탈로그

10.4 유형 1 SBS-IF에 있는 GLOBAL CORE SBS-IF 시장 (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, REGION, 2018-2033에 의하여, (USD THOUSAND)

10.4.1 북아메리카

10.4.2 유로

10.4.3 아시아 수출

10.4.4 중동과 아프리카

10.4.5 SOUTH 아메리카

10.5 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

10.5.1 ANTI-DIARRHEALS의 특징

10.5.2의 PPIS

10.5.3 분석

10.6 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME), REGION, 2018-2033, (USD THOUSAND)

10.6.1 북아메리카

10.6.2 유로

10.6.3 아시아 수출

10.6.4 중동과 아프리카

10.6.5 남쪽 AMERICA

10.7 글로벌 ADJACENT / NON-SPECIFIC MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

10.7.1 북아메리카

10.7.2 유로

10.7.3 아시아 수출

10.7.4 중동과 아프리카

10.7.5 남쪽 AMERICA

11 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 SHORT BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE

11.1 전망

11.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

11.2.1 교류 PHASE (TYPE 1 SBS-IF)

11.2.2 개정 PHASE

11.2.3 복구 PHASE

11.3 GLOBAL ACUTE PHASE (TYPE 1 SBS-IF) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, REGION, 2018-2033, (USD THOUSAND)

11.3.1 북아메리카

11.3.2 유로

11.3.3 아시아 수출

11.3.4 중동 및 아프리카

11.3.5 SOUTH 아메리카

11.4 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

11.4.1 북아메리카

11.4.2 유로

11.4.3 아시아 수출

11.4.4 중동과 아프리카

11.4.5 SOUTH 아메리카

11.5 GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

11.5.1 북아메리카

11.5.2 유로

11.5.3 아시아 수출

11.5.4 중동과 아프리카

11.5.5 남쪽 AMERICA

12 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE

12.1 전망

12.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

12.2.1 에어

12.2.2 포장

12.3 글로벌 ADULT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

12.3.1 북아메리카

12.3.2 유로

12.3.3 아시아 수출

12.3.4 중동과 아프리카

12.3.5 SOUTH 아메리카

12.4 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

12.4.1 북아메리카

12.4.2 유로

12.4.3 아시아 수출

12.4.4 MIDDLE 동쪽과 아프리카

12.4.5 SOUTH 아메리카

13 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 광고의 ROUTE에 의해

13.1 전망

13.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

13.2.1 주변

13.2.2 직원

13.2.3 주문

13.2.4 외부

13.3 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

13.3.1 팬

13.3.2 접속 가능

13.4 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

13.4.1 북아메리카

13.4.2 유로

13.4.3 아시아 수출

13.4.4 중동과 아프리카

13.4.5 SOUTH 아메리카

13.5 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

13.5.1 북아메리카

13.5.2 유로

13.5.3 아시아 수출

13.5.4 중동과 아프리카

13.5.5 SOUTH 아메리카

13.6 글로벌 ORAL IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

13.6.1 북아메리카

13.6.2 유로

13.6.3 아시아 수출

13.6.4 중동과 아프리카

13.6.5 남쪽 AMERICA

13.7 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

13.7.1 북아메리카

13.7.2 유로

13.7.3 아시아 수출

13.7.4 MIDDLE 동쪽과 아프리카

13.7.5 남쪽 AMERICA

14 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, END USER로

14.1 전망

14.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, END USER, 2018-2033 (USD THOUSAND)

14.2.1 병원(ACUTE CARE)

14.2.2 홈케어 (HPN PROGRAMS)

14.2.3 ICU 설정

14.2.4 PECIALTY GI 센터

14.2.5 PEDIATRIC 안전 보증

14.3 GLOBAL HOSPITALS (ACUTE CARE) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

14.3.1 북아메리카

14.3.2 유로

14.3.3 아시아 수출

14.3.4 중동과 아프리카

14.3.5 SOUTH 아메리카

14.4 GLOBAL HOME CARE (HPN PROGRAMS) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

14.4.1 북아메리카

14.4.2 유로

14.4.3 아시아 수출

14.4.4 MIDDLE 동쪽과 아프리카

14.4.5 SOUTH 아메리카

14.5 GLOBAL ICU SETTINGS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) REGION, 2018-2033, (USD THOUSAND)

14.5.1 북아메리카

14.5.2 유로

14.5.3 아시아 수출

14.5.4 중동과 아프리카

14.5.5 SOUTH 아메리카

14.6 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

14.6.1 북아메리카

14.6.2 유로

14.6.3 아시아 수출

14.6.4 중동과 아프리카

14.6.5 SOUTH 아메리카

14.7 GLOBAL PEDIATRIC SPECIALTY HOSPITALS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

14.7.1 북아메리카

14.7.2 유로

14.7.3 아시아 수출

14.7.4 MIDDLE 동쪽과 아프리카

14.7.5 남쪽 AMERICA

15 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 분산 사슬로

15.1 전망

15.2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

15.2.1 병원성

15.2.2 안전 PHARMACY

15.2.3 세부사항 PHARMACY

15.2.4 온라인 PHARMACY

15.3 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, 2018-2033, (USD THOUSAND)

15.3.1 북아메리카

15.3.2 유로

15.3.3 아시아 수출

15.3.4 중동 및 아프리카

15.3.5 SOUTH 아메리카

15.4 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033, (USD THOUSAND)

15.4.1 북아메리카

15.4.2 유로

15.4.3 아시아 수출

15.4.4 MIDDLE 동쪽과 아프리카

15.4.5 SOUTH 아메리카

15.5 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033, (USD THOUSAND)

15.5.1 북아메리카

15.5.2 유로

15.5.3 아시아 수출

15.5.4 중동과 아프리카

15.5.5 남쪽 AMERICA

16 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION

16.1 전망

16.2 북아메리카

16.2.1 미국

16.2.2 캐나다

16.2.3 멕시코

16.3 유로

16.3.1 독일

16.3.2 미국

16.3.3 팬티

16.3.4 이탈리아

16.3.5 스페인

16.3.6 열쇠

16.3.7 러시아

16.3.8 네덜란드

16.3.9 스위스

16.3.10 프리미엄

16.3.11 스웨덴

16.3.12 덴마크

16.3.13 고속도로

16.3.14 핀란드

16.3.15 EUROPE의 등급

16.4 아시아 패시픽

16.4.1 일본

16.4.2 중국

16.4.3 SOUTH 한국

16.4.4 인도

16.4.5 가수

16.4.6 태국

16.4.7 인도

16.4.8 마리아

16.4.9 필립스

16.4.10 프리미엄

16.4.11 새로운 땅

16.4.12 홍콩

16.4.13 대만

16.4.14 아시아-파시텍의 연구

16.5 남쪽 AMERICA

16.5.1 브라질

16.5.2 아군테나

16.5.3 코로바니아

16.5.4 가공

16.5.5 페루

16.5.6 ECU 어댑터

16.5.7 우루과이

16.5.8 VENEZUELA.

16.5.9 발리

16.5.10 파라과이

16.5.11 SOUTH AMERICA의 상승

16.6 MIDDLE 동쪽과 아프리카

16.6.1 사우아 아르ABIA

16.6.2 남쪽 AFRICA

16.6.3 과

16.6.4 인치

16.6.5 단위 ARAB EMIRATES

16.6.6 쿠와이트

16.6.7 오만

16.6.8캐럿

16.6.9 바레인

중동 및 아프리카의 16.6.10 상승

17 GLOBAL GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 회사 LANDSCAPE

17.1 MANUFACTURER COMPANY 샤인 분석: GLOBAL

17.2 MANUFACTURER COMPANY는 ANALYSIS를 공유합니다: ASIA-PACIFIC

17.3 MANUFACTURER COMPANY 샤이 분석 : 유럽

17.4 MANUFACTURER COMPANY 샤인 분석 : NORTH AMERICA

18 SWOT 분석

19 회사소개

19.1 피에르니우스 KABI

19.1.1 회사 SNAPSHOT

19.1.2 REVENUE 분석

19.1.3 회사 ANALYSIS

19.1.4 제품포트폴리오

19.1.5 수익률

19.2 BAXTER 국제 INC.

19.2.1 회사 SNAPSHOT

19.2.2 REVENUE 분석

19.2.3 회사 ANALYSIS

19.2.4 제품포장

19.2.5 유지 보수

19.3 NESTLÉ 건강 과학

19.3.1 회사 SNAPSHOT

19.3.2 REVENUE 분석

19.3.3 회사 ANALYSIS

19.3.4 제품 PORTFOLIO

19.3.5 유지 보수

19.4 ABBOTT 장비

19.4.1 회사 SNAPSHOT

19.4.2 REVENUE 분석

19.4.3 회사 ANALYSIS

19.4.4 제품 PORTFOLIO

19.4.5 유지 보수

제한되는 19.5 TAKEDA PHARMACEUTICAL COMPANY

19.5.1 회사 SNAPSHOT

19.5.2 REVENUE 분석

19.5.3 회사 ANALYSIS

19.5.4 제품 PORTFOLIO

19.5.5 RECENT 개발

19.6 MOOG 회사

19.6.1 회사 SNAPSHOT

19.6.2 REVENUE 분석

19.6.3 제품포트폴리오

19.6.4 RECENT 개발/뉴스

19.7 수명 관리

19.7.1 회사 SNAPSHOT

19.7.2 제품포장

19.7.3 수익률

19.8 AMSINO 국제, INC

19.8.1 회사 SNAPSHOT

19.8.2 제품포트폴리오

19.8.3 재결합

19.9 AURORA 건강 관리

19.9.1 회사 SNAPSHOT

19.9.2 제품포장

19.9.3 수익 창출

19.1 AMERIPHARMA 특별 관리.

19.10.1 회사 SNAPSHOT

19.10.2 제품포트폴리오

19.10.3 수익률

19.11 BAUSCH 건강용품 INC

19.11.1 회사 SNAPSHOT

19.11.2 REVENUE 분석

19.11.3 제품포트폴리오

19.11.4 수익 창출

19.12 BEVELRYHILLS 다이브 케어

19.12.1 회사 SNAPSHOT

19.12.2 제품포트폴리오

19.12.3 유지 보수

19.13 B. BRAUN SE의

19.13.1 회사 SNAPSHOT

19.13.2 제품포트폴리오

19.13.3 수익 창출

19.14 캠비타

19.14.1 회사 SNAPSHOT

19.14.2 제품 PORTFOLIO

19.14.3 수익 창출

19.15 CHOICE PARENTERAL NUTRITION LLC (주)

19.15.1 회사 SNAPSHOT

19.15.2 제품포트폴리오

19.15.3 수익 창출

19.16 CONTINUUMRX

19.16.1 회사 SNAPSHOT

19.16.2 제품 포트폴리오

19.16.3 수익률

19.17 봄 무기

19.17.1 회사 SNAPSHOT

19.17.2 제품 PORTFOLIO

19.17.3 유지 관리

19.18년 GRIFOLS S.A.

19.18.1 회사 SNAPSHOT

19.18.2 리베니아 분석

19.18.3 제품포트폴리오

19.18.4 비용 절감

19.19 HIKMA 제약

19.19.1 회사 SNAPSHOT

19.19.2 리베니아 분석

19.19.3 제품 PORTFOLIO

19.19.4 유지 보수

19.2 HOSPIRA (PART OF PFIZER INC.)

19.20.1 회사 SNAPSHOT

19.20.2 REVENUE 분석

19.20.3 제품 PORTFOLIO

19.20.4 수익률

(주)한미제약

19.21.1 회사 SNAPSHOT

19.21.2 리베니아 분석

19.21.3 제품포트폴리오

19.21.4 수익률

19.22 ICU 의료, INC.

19.22.1 회사 SNAPSHOT

19.22.2 REVENUE 분석

19.22.3 제품포트폴리오

19.22.4 유지 관리

19.23 INFUSION 솔루션

19.23.1 회사 SNAPSHOT

19.23.2 제품포트폴리오

19.23.3 수익률

19.24 INTEGRATED CARE 시스템

19.24.1 회사 SNAPSHOT

19.24.2 제품 PORTFOLIO

19.24.3 수익 창출

제한되는 19.25 JEDUX PARENTERAL PRIVATE

19.25.1 회사 SNAPSHOT

19.25.2 제품포트폴리오

19.25.3 수익률

19.26 LABORATOIRE 디젤

19.26.1 회사 SNAPSHOT

19.26.2 제품 PORTFOLIO

19.26.3 수익률

19.27 NAPO 이론.

19.27.1 회사 SNAPSHOT

19.27.2 제품 PORTFOLIO

19.2 수익/뉴스

19.28 NUTREGO, 영국

19.28.1 회사 SNAPSHOT

19.28.2 제품포트폴리오

19.28.3 수익률

19.29 NUTRICIA (단일 그룹)

19.29.1 회사 SNAPSHOT

19.2 리베니아 분석

19.29.3 제품포트폴리오

19.29.4 수익률

19.3 NUTRICIA 북아메리카

19.30.1 회사 쇼

19.30.2 제품포트폴리오

19.30.3 수익률

19.31 NUTRISHARE의 특징

19.31.1 회사 SNAPSHOT

19.31.2 제품포트폴리오

19.31.3 유지 관리

19.32 옥스포드

19.32.1 회사 SNAPSHOT

19.32.2 제품포트폴리오

19.32.3 등록 완료

주식회사 19.33 PHARMKO

19.33.1 회사 SNAPSHOT

19.33.2 제품포트폴리오

19.33.3 수익 창출

19.34 PUERTO 생명 과학 PVT. LTD.

19.34.1 회사 SNAPSHOT

19.34.2 제품 PORTFOLIO

19.34.3 수익 창출

19.35 SHANDONG QIDU PHARMACEUTICAL CO., 주식 회사.

19.35.1 회사 SNAPSHOT

19.35.2 제품포트폴리오

19.35.3 수익 창출

19.36 STANFORD 건강 관리

19.36.1 회사 SNAPSHOT

19.36.2 제품 PORTFOLIO

19.36.3 수익률

19.37 UF 건강

19.37.1 회사 SNAPSHOT

19.37.2 제품 PORTFOLIO

19.37.3 등록

19.38 아이론우드 패럴림픽

19.38.1 회사 SNAPSHOT

19.38.2 리베니아 분석

19.38.3 제품포트폴리오

19.38.4 비용 절감

19.39 비전 PARENTERAL

19.39.1 회사 SNAPSHOT

19.39.2 제품포트폴리오

19.39.3 RECENT 개발

19.4 건포도

19.40.1 회사 SNAPSHOT

19.40.2 REVENUE 분석

19.40.3 제품 PORTFOLIO

19.40.4 손실

20 질문

21 관련 보고서

표 목록

TABLE 1 SBI-IF PATIENTS의 거래 비율

TABLE 2 ESTIMATED THERAPY-SPECIFIC PATIENT 공구

TABLE 3 영원한 FUNNEL PATEGINTS

TABLE 4 KEY 산업 INSIGHTS AND MARKET TRENDS IN GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장

전 세계 TYPE 1 SBS-IF TREATMENT MARKET ECOSYSTEM 및 INDUSTRY RESPONSE FRAMEWORK의 5 IMPACT

6 PHASE GLOBAL TYPE 1 SBS-IF MARKET의 제품 및 프로젝트의 배포

SCIENTIFIC APPROACH 및 PHASE – GLOBAL TYPE 1 SBS-IF 시장

기타 지역 및 PHASE의 프로젝트의 8 DISTRIBUTION – GLOBAL TYPE 1 SBS-IF 시장

TABLE 9 PIPELINE LANDSCAPE 및 의료 기기 개요

TABLE 10 R&D GLANCE에 TOP ENTITIES 기초 – GLOBAL TYPE 1 SBS-IF TREATMENT 시장

테이블 11 PRECLINICAL/RESEARCH STAGE VACCINE CANDIDATES

TABLE 12 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 13 GLOBAL NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)로 구성된 세계적 수준의 지원

TABLE 14 GLOBAL PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 15 GLOBAL TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 16 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 17 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 18 GLOBAL ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 19 GLOBAL TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 20 GLOBAL FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 21 GLOBAL PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 22 GLOBAL MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 23 유형 1 SBS-IF에 있는 세계적인 MICRONUTRIENTS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 24 GLOBAL NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (미스터드)

TABLE 25 GLOBAL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

26 GLOBAL HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 27 GLOBAL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 28 GLOBAL GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 29 GLOBAL IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 30 GLOBAL ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 31 GLOBAL OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 32 GLOBAL ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 33 GLOBAL PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 34 GLOBAL SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)

TABLE 35 GLOBAL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 36 GLOBAL MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 37 GLOBAL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

38 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 39 GLOBAL BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 40 GLOBAL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

TABLE 41 GLOBAL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 42 GLOBAL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 43 GLOBAL OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 44 GLOBAL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 45 GLOBAL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 46 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 47 GLOBAL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 48 GLOBAL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 49 GLOBAL GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 50 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 51 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 52 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 53 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 54 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 55 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

TABLE 56 GLOBAL ADJACENT / NON-SPECIFIC MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 57 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 58 GLOBAL ACUTE PHASE (TYPE 1 SBS-IF) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, REGION에 의해 2018-2033, (USD THOUSAND)

TABLE 59 GLOBAL ADAPTATION PHASE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

TABLE 60 GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 61 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 62 GLOBAL ADULT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

TABLE 63 GLOBAL PEDIATRIC IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 시장, 2018-2033, (USD THOUSAND)

TABLE 64 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 65 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 66 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 67 GLOBAL SUBCUTANEOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 68 GLOBAL ORAL IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

TABLE 69 GLOBAL ENTERAL IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 시장, 2018-2033, (USD THOUSAND)

TABLE 70 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

TABLE 71 GLOBAL HOSPITALS (ACUTE CARE) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 72 GLOBAL HOME CARE (HPN PROGRAMS) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME), REGION, 2018-2033, (USD THOUSAND)

TABLE 73 GLOBAL ICU SETTINGS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

TABLE 74 GLOBAL SPECIALTY GI CENTERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

TABLE 75 GLOBAL PEDIATRIC SPECIALTY HOSPITALS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 76 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 77 GLOBAL HOSPITAL PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 78 GLOBAL SPECIALTY PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 79 GLOBAL RETAIL PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

테이블 80 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033, (USD THOUSAND)

TABLE 81 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 82 GLOBAL NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 83 GLOBAL PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 84 GLOBAL TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 85 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 86 GLOBAL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

ABLE 87 GLOBAL ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 88 GLOBAL TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 89 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 90 GLOBAL PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 91 GLOBAL MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 92 GLOBAL MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 93 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, REGION, 2018-2033, (USD THOUSAND)

ABLE 94 GLOBAL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 95 GLOBAL HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 96 GLOBAL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 97 GLOBAL GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 98 GLOBAL IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

99 GLOBAL ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 100 GLOBAL OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 101 GLOBAL ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 102 GLOBAL PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 103 GLOBAL SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)

TABLE 104 GLOBAL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 105 GLOBAL MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 106 GLOBAL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 107 GLOBAL BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 108 GLOBAL BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 109 GLOBAL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 110 GLOBAL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 111 GLOBAL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 112 GLOBAL OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 113 GLOBAL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 114 GLOBAL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

TABLE 115 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 116 GLOBAL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 117 GLOBAL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 118 GLOBAL GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 119 GLOBAL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 120 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 121 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 122 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 123 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 124 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 125 GLOBAL ADJACENT / NON-SPECIFIC MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

케이블 126 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 127 GLOBAL ACUTE PHASE (TYPE 1 SBS-IF) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

TABLE 128 GLOBAL ADAPTATION PHASE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION, 2018-2033, (USD THOUSAND)

TABLE 129 GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 130 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 131 GLOBAL ADULT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

TABLE 132 GLOBAL PEDIATRIC IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 시장, 2018-2033, (USD THOUSAND)

TABLE 133 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 134 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 135 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 136 GLOBAL SUBCUTANEOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 137 GLOBAL ORAL IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033, (USD THOUSAND)

TABLE 138 IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033, (USD THOUSAND)

TABLE 139 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER에 의해, 2018-2033 (USD THOUSAND)

TABLE 140 GLOBAL HOSPITALS (ACUTE CARE) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 141 GLOBAL HOME CARE (HPN PROGRAMS) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 142 GLOBAL ICU SETTINGS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

TABLE 143 GLOBAL SPECIALTY GI CENTERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033, (USD THOUSAND)

TABLE 144 GLOBAL PEDIATRIC SPECIALTY HOSPITALS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 145 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 146 GLOBAL HOSPITAL PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 147 GLOBAL SPECIALTY PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033, (USD THOUSAND)

TABLE 148 GLOBAL RETAIL PHARMACY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, REGION에 의해, 2018-2033, (USD THOUSAND)

TABLE 149 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 150 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 151 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

ABLE 152 NORTH AMERICA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 153 NORTH AMERICA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 154 NORTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

155 NORTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

156 NORTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 157 NORTH AMERICA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 158 NORTH AMERICA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 159 NORTH AMERICA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 160 NORTH AMERICA PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 161 NORTH AMERICA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 162 NORTH AMERICA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 163 NORTH AMERICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 164 NORTH AMERICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 165 NORTH AMERICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 166 NORTH AMERICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 167 NORTH AMERICA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

케이블 168 NORTH AMERICA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 169 NORTH AMERICA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 170 NORTH AMERICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 171 NORTH AMERICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 172 NORTH AMERICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 173 NORTH AMERICA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 174 NORTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 175 NORTH AMERICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 176 NORTH AMERICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 177 NORTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 178 NORTH AMERICA 농업 & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 179 NORTH AMERICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 180 NORTH AMERICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 181 NORTH AMERICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 182 NORTH AMERICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 183 NORTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 184 NORTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 185 NORTH AMERICA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 186 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 187 NORTH AMERICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 188 NORTH AMERICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 189 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 190 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 191 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 192 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 193 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 194 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 195 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 196 미국 NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 197 미국 PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 198 미국 TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 199 US HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 200 US HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 201 미국 ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 202 미국 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 203 미국 FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 204 미국 PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 205 미국 MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 206 미국 MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 207 미국 PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 208 미국 HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 209 미국 GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

ABLE 210 미국 GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 211 미국 IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 212 미국 ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 213 미국 OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 214 미국 ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 215 미국 PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 216 미국 SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 217 미국 H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 218 미국 MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 219 미국 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

케이블 220 미국 바이어 방식 및 ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 221 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 222 미국 환경 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 보웰 SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 223 미국 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 224 미국 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 225 미국 INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 226 미국 EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 227 미국 REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 228 미국 MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 229 미국 GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 230 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, MARKET ATTRIBUTION에 의하여, 2018-2033 (USD THOUSAND)

TABLE 231 미국 CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 232 미국 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 233 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 놀이쇠 SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (미래되는 USD)

TABLE 234 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, PATIENT 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 235 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 2018-2033의 도로에 의하여, (USD THOUSAND)

TABLE 236 미국 INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 237 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, END USER에 의하여, 2018-2033 (USD THOUSAND)

TABLE 238 미국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 239 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 240 CANADA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 241 CANADA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 242 CANADA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 243 캐나다 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 244 CANADA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 245 CANADA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 246 CANADA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 247 CANADA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 248 CANADA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 249 CANADA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 250 CANADA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 251 CANADA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 252 CANADA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 253 CANADA GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 254 CANADA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 255 CANADA IGF-1 & 유형 1 SBS-IF에 있는 ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 256 CANADA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 257 CANADA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 258 CANADA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 259 CANADA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 260 캐나다 SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 261 CANADA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 262 CANADA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 263 CANADA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 264 CANADA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 265 CANADA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 266 CANADA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 267 CANADA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 268 캐나다 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 269 CANADA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 270 CANADA EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 271 CANADA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 272 CANADA MICROBIOME-BASED THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 273 CANADA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 274 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 275 CANADA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 276 CANADA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 277 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 278 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 279 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 280 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 281 CANADA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

테이블 282 캐나다 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 저장소, 2018-2033 (USD THOUSAND)

TABLE 283 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 284 MEXICO NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 285 MEXICO PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 286 MEXICO TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 287 MEXICO HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 288 MEXICO HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 289 MEXICO ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 290 MEXICO TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 291 MEXICO FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 292 MEXICO PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 293 MEXICO MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 294 MEXICO MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 295 MEXICO PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 296 MEXICO HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 297 MEXICO GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 298 MEXICO GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 299 MEXICO IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 300 MEXICO ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 301 MEXICO OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 302 MEXICO ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 303 MEXICO PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 304 MEXICO SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 305 MEXICO H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 306 MEXICO MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 307 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 308 MEXICO BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 309 MEXICO BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 310 MEXICO SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 311 MEXICO INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 312 MEXICO OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 313 MEXICO INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 314 MEXICO EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 315 MEXICO REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 316 MEXICO MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 317 MEXICO GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 318 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 319 MEXICO CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 320 MEXICO SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 321 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배제 관리 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 322 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 323 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 324 MEXICO INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 325 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 326 MEXICO TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 327 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 328 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 329 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

ABLE 330 EUROPE NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 331 EUROPE PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 332 EUROPE TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 333 EUROPE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 334 EUROPE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 335 EUROPE ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 336 EUROPE 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 337 EUROPE FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 338 EUROPE PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 339 EUROPE MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 340 EUROPE MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 341 EUROPE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 342 EUROPE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 343 EUROPE GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 344 EUROPE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 345 EUROPE IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 346 EUROPE ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 347 EUROPE OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 348 EUROPE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 349 EUROPE PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 350 EUROPE SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 351 EUROPE H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 352 EUROPE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 353 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 354 EUROPE BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 355 EUROPE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 356 EUROPE SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 357 EUROPE INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 358 EUROPE OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 359 EUROPE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 360 EUROPE EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 361 EUROPE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 362 EUROPE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 363 EUROPE GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 364 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 365 EUROPE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 366 EUROPE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 367 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질, 2018-2033 (USD THOUSAND)

TABLE 368 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 369 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 370 EUROPE INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 371 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 372 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 373 USD 기타

TABLE 374 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 375 GERMANY NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 376 GERMANY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 377 GERMANY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 378 GERMANY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 379 GERMANY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 380 GERMANY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 381 독일 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 382 GenRMANY FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 383 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 384 GenRMANY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 385 유형 1 SBS-IF에 있는 독일 MICRONUTRIENTS (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 386 GERMANY PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 볼륨 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 387 GERMANY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 388 GenRMANY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 389 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 HORMONE 다른 사람) 무역 시장, SOMATROPIN-BASED에 의하여, 2018-2033 (USD THOUSAND)

TABLE 390 GERMANY IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 391 GERMANY ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 392 GERMANY OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 393 GERMANY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 394 GERMANY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 395 GERMANY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 396 GERMANY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 397 GERMANY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 398 GERMANY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 399 GERMANY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

유형 1 SBS-IF (INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 401 GERMANY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 402 GERMANY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 403 GERMANY OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 404 GERMANY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 405 GERMANY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 406 GERMANY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 407 GERMANY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 408 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 409 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

ABLE 410 GERMANY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 411 GERMANY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 412 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

413 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 414 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 415 GERMANY INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 416 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 417 GERMANY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

테이블 418 USD 묶음

TABLE 419 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 420 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 심판 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 421 U.K. PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 422 U.K. TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 423 U.K. HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

424 U.K. HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 425 U.K. ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 426 U.K. TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 427 U.K. FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 428 U.K. PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 429 U.K. 유형에 있는 MACRONUTRIENTS 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (미리한 USD)

TABLE 430 U.K. MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 431 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 화학 물질 대사

TABLE 432 U.K. HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 433 U.K. GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 434 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 심판 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 435 U.K. IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 436 미국 ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 437 U.K. OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 438 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 ANTI-SECRETORY 다른 사람

TABLE 439 U.K. PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 440 U.K. 유형에 있는 SOMATOSTATIN ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 441 U.K. H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 442 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 미크론 간격

TABLE 443 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 완전한 다른 사람

TABLE 444 U.K. BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 445 U.K. 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 외면 ACID SEQUESTRANTS

TABLE 446 U.K. 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 447 U.K. INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 448 U.K. OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 449 U.K. INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 450 U.K. EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 451 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)의 REGENERATIVE MEDICINE

TABLE 452 U.K. MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 453 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)으로 다른 사람

TABLE 454 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 455 U.K. CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 456 U.K. SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 457 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 458 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 459 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 460 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 461 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 462 U.K. TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 463 USD 기타

TABLE 464 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 465 FRANCE NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 466 FRANCE PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 467 FRANCE TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 468 FRANCE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 469 FRANCE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 470 FRANCE ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 471 FRANCE 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 472 FRANCE FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 473 FRANCE PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 474 FRANCE MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 475 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 476 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 477 FRANCE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 478 FRANCE GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 479 유형 1 SBS-IF (INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 480 FRANCE IGF-1 & ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 481 FRANCE ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 482 FRANCE OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 483 FRANCE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 484 FRANCE PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 485 FRANCE SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 486 FRANCE H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 487 FRANCE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 488 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 489 FRANCE BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 490 FRANCE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 491는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME를 가진 유형 1개의 SBS-IF (SHORT BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 492 FRANCE INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 493 FRANCE OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 494 FRANCE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 495 FRANCE EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 496 FRANCE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 497 FRANCE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 498 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME)에 있는 FRANCE 다른 사람, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 499 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION에 의하여, 2018-2033 (USD THOUSAND)

TABLE 500 FRANCE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 501 FRANCE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 502 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

케이블 503 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 504 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 505 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 506 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 507 FRANCE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 508 USD 기타

TABLE 509 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 510 ITALY NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 511 ITALY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

512 ITALY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

513 ITALY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 514 ITALY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 515 ITALY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

516 ITALY TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 517 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 518 ITALY PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 519 ITALY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

ABLE 520 ITALY MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 521 ITALY PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

522 ITALY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 523 ITALY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

524 ITALY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 심판 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 525 ITALY IGF-1 & ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 526 ITALY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 527 ITALY OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 528 ITALY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 529 ITALY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 530 ITALY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 531 ITALY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 532 ITALY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 533 ITALY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 534 ITALY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 535 ITALY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 536 ITALY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 537 ITALY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 538 ITALY OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 짧은 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 539 ITALY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 540 ITALY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 541 ITALY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 542 ITALY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 543 TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이티 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 544 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 545 ITALY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 546 ITALY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 547 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 배설물 PHASE에 의하여, 2018-2033 (미들랜드)

TABLE 548 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 549 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 550 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 551 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 552 ITALY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 553 USD 기타

TABLE 554 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 555 SPAIN NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 556 SPAIN PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 557 SPAIN TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 558 SPAIN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 559 SPAIN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 560 SPAIN ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 561 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 562 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME)에 있는 포뮬라 유형, 2018-2033 (USD THOUSAND)

TABLE 563 SPAIN PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 564 SPAIN MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 565 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 566 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 567 SPAIN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 568 유형 1 SBS-IF에 있는 스페인 GLP-2 ANALOGUES (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 569 SPAIN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

유형 1 SBS-IF에 있는 케이블 570 스페인 IGF-1 & ANALOGUES (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 571 SPAIN ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 572 SPAIN OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 573 SPAIN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 574 SPAIN PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 575 스페인 SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 576 SPAIN H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 577 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 578 SPAIN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 579 SPAIN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 580 SPAIN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 581 SPAIN SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 582 SPAIN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 583 SPAIN OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 584 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 585 SPAIN EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 586 유형 1 SBS-IF (INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 587 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 588 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 589 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 590 SPAIN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 591 SPAIN SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 592 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 593 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 594 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 595 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 596 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 597 SPAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 598 USD 기타

TABLE 599 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 600 TURKEY NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 601 TURKEY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 602 TURKEY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 603 TURKEY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 604 TURKEY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 605 TURKEY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 606 TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 607 TURKEY FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 608 TURKEY PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 609 TURKEY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 610 TURKEY MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 611 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

612 TURKEY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 613 TURKEY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

614 TURKEY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 615 열쇠 IGF-1 & 유형 1 SBS-IF에 있는 ANALOGUES (INTESTINAL FAILURE를 가진 마개 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 616 TURKEY ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 617 TURKEY OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 618 TURKEY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 619 TURKEY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 620 TURKEY SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 621 TURKEY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 622 TURKEY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 623 TURKEY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 624 TURKEY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 625 TURKEY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 626 TURKEY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 627 TURKEY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 628 TURKEY OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 629 TURKEY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 630 TURKEY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 631 TURKEY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 632 TURKEY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 633 TURKEY GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 634 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 635 TURKEY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 636 TURKEY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 637 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 면세 물질 PHASE, 2018-2033 (USD THOUSAND)

TABLE 638 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 639 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

640 TURKEY INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 641 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 642 TURKEY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 643 USD 기타

TABLE 644 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

645 RUSSIA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 646 RUSSIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 647 RUSSIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 648 러시아 홈 패런션 (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

TABLE 649 RUSSIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 650 RUSSIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 651 RUSSIA 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 652 RUSSIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 653 러시아 PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 654 RUSSIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 655 RUSSIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 656 RUSSIA PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 657 RUSSIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 658 RUSSIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 659 RUSSIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 660 RUSSIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 661 RUSSIA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 662 RUSSIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 663 RUSSIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 664 RUSSIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 665 RUSSIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 666 RUSSIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 667 RUSSIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 668 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 669 RUSSIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 670 RUSSIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 671 RUSSIA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 672 RUSSIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 673 RUSSIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 674 RUSSIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 675 RUSSIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 676 RUSSIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 677 RUSSIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 678 RUSSIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 679 러시아 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 시장 분석, 2018-2033 (USD THOUSAND)

TABLE 680 RUSSIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 681 RUSSIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 682 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 시장, 배율 분석, 2018-2033 (USD THOUSAND)

TABLE 683 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 684 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 685 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 686 러시아 TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

테이블 687 RUSSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배포 채널, 2018-2033 (USD THOUSAND)

TABLE 688 USD 기타

TABLE 689 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 690 NETHERLANDS NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 691 NETHERLANDS PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 692 NETHERLANDS TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 693 NETHERLANDS HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 694 NETHERLANDS HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 695 NETHERLANDS ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 696 NETHERLANDS TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 697 NETHERLANDS FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 698 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 699 NETHERLANDS MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 700 NETHERLANDS MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 701 NETHERLANDS PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 702 NETHERLANDS HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 703 NETHERLANDS GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 704 NETHERLANDS GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 705 NETHERLANDS IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 706 NETHERLANDS ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 707 NETHERLANDS OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 708 NETHERLANDS ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 709 NETHERLANDS PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 710 NETHERLANDS SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 711 NETHERLANDS H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 712 NETHERLANDS MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 713 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 714 NETHERLANDS BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 715 NETHERLANDS BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 716 NETHERLANDS 농업 & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 717 NETHERLANDS INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 718 NETHERLANDS OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 719 NETHERLANDS INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 720 NETHERLANDS EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 721 NETHERLANDS REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 722 NETHERLANDS MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 723 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 724 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)

TABLE 725 NETHERLANDS CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 726 NETHERLANDS SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 727 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 728 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 729 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 730 NETHERLANDS INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 731 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 732 NETHERLANDS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 733 USD 기타

TABLE 734 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 735 SWITZERLAND NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 736 SWITZERLAND PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 737 SWITZERLAND TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 738 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 739 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 740 SWITZERLAND ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 741 SWITZERLAND TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 742 SWITZERLAND FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 743 SWITZERLAND PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 744 SWITZERLAND MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 745 SWITZERLAND MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 746 SWITZERLAND PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 747 SWITZERLAND HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 748 SWITZERLAND GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 749 SWITZERLAND 다른 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 750 SWITZERLAND IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 751 SWITZERLAND ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 752 SWITZERLAND OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 753 SWITZERLAND ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 754 SWITZERLAND PROTON PUMP INHIBITORS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 755 SWITZERLAND SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 756 SWITZERLAND H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 757 SWITZERLAND MICRONUTRIUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 758 SWITZERLAND ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 759 SWITZERLAND BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 760 SWITZERLAND BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 761 SWITZERLAND SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 762 SWITZERLAND INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 763 SWITZERLAND OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 764 SWITZERLAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 765 SWITZERLAND EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 766 SWITZERLAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 767 SWITZERLAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 768 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 두목) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 769 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 770 SWITZERLAND CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 771 SWITZERLAND SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 772 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 773 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 774 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 775 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 776 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

TABLE 777 SWITZERLAND TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 778 USD 기타

TABLE 779 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 780 BELGIUM NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 781 BELGIUM PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 782 BELGIUM TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 783 BELGIUM HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 784 BELGIUM HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 785 BELGIUM ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 786 BELGIUM TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 787 BELGIUM FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 788 BELGIUM PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 789 BELGIUM MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 790 TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 791 BELGIUM PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 792 BELGIUM HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 793 BELGIUM GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 794 BELGIUM GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 795 BELGIUM IGF-1 & ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 796 BELGIUM ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 797 BELGIUM OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 798 BELGIUM ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 799 BELGIUM PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 800 BELGIUM SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 801 BELGIUM H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 802 BELGIUM MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 803 BELGIUM ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

804 BELGIUM BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 805 BELGIUM BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 806 BELGIUM SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 807 BELGIUM INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 808 BELGIUM OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 809 BELGIUM INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 810 BELGIUM EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 811 BELGIUM REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 812 BELGIUM MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 813 BELGIUM GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 814 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 815 BELGIUM CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 816 BELGIUM SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 817 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 818 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 819 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 820 BELGIUM INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 821 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

테이블 822 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 823 USD 기타

TABLE 824 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 825 SWEDEN NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 826 SWEDEN PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 827 SWEDEN TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 828 스위덴 홈 패런던트 (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 보웰 SYNDROME) 트레이드 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 829 SWEDEN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 830 SWEDEN ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 831 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 832 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 833 SWEDEN PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT 시장, 유형에 의해, 2018-2033 (USD THOUSAND)

TABLE 834 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 835 SWEDEN MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 836 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 837 SWEDEN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 838 SWEDEN GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 839 SWEDEN GROWTH HORMONE THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 840 SWEDEN IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 841 SWEDEN ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 842 SWEDEN OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 843 SWEDEN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 844 SWEDEN PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 845 SWEDEN SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 846 SWEDEN H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 847 SWEDEN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 848 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 849 SWEDEN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 851 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME를 가진 SHORT BOWEL SYNDROME) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 852 SWEDEN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 853 SWEDEN OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 854 SWEDEN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 855 SWEDEN EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 856 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)와 함께 SHORT BOWEL SYNDROME

TABLE 857 SWEDEN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 858 SWEDEN GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 859 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)

TABLE 860 SWEDEN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 861 SWEDEN SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 862 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질, 2018-2033 (USD THOUSAND)

TABLE 863 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 864 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 865 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 866 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 867 SWEDEN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 868 USD 기타

TABLE 869 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 870 DENMARK NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 871 DENMARK PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 872 DENMARK TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

873 DENMARK HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 874 덴마크 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 875 덴마크 ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 876 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 877 DENMARK FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 878 DENMARK PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 879 DENMARK MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 880 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 881 DENMARK PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 882 DENMARK HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 883 DENMARK GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 884 DENMARK GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 885 DENMARK IGF-1 & ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 886 DENMARK ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 887 DENMARK OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 888 DENMARK ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 889 DENMARK PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 890 DENMARK SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 891 DENMARK H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 892 DENMARK MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 893 DENMARK ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 894 DENMARK BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 895 DENMARK BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 896 DENMARK SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 897 DENMARK INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 898 DENMARK OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 899 DENMARK INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 900 DENMARK EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 901 DENMARK REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 902 DENMARK MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 903 DENMARK GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 904 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 905 DENMARK CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 906 DENMARK SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 907 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질, 2018-2033 (USD THOUSAND)

TABLE 908 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 909 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 910 DENMARK INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 911 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 912 DENMARK TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 913 USD 기타

TABLE 914 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 915 NORWAY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 916 NORWAY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 917 NORWAY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 918 NORWAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 919 NORWAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 920 NORWAY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 921 NORWAY TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 922 NORWAY FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 923 NORWAY PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 924 NORWAY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 925 NORWAY MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 926 NORWAY PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 927 NORWAY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 928 NORWAY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 929 NORWAY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 930 NORWAY IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 931 NORWAY ANTI-DIARRHEAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 932 NORWAY OPIOID-BASED TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 933 NORWAY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 934 NORWAY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 935 NORWAY SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 936 NORWAY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 937 NORWAY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 938 NORWAY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 939 NORWAY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 940 NORWAY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 941 NORWAY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 942 NORWAY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 943 NORWAY OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 944 NORWAY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 945 NORWAY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 946 NORWAY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 947 NORWAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 948 NORWAY GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 949 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

ABLE 950 NORWAY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 951 NORWAY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 952 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 953 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 954 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 955 NORWAY INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 956 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 957 NORWAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 958 USD 기타

TABLE 959 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 960 FINLAND NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 961 FINLAND PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 962 FINLAND TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 963 FINLAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 964 FINLAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 965 FINLAND ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 966 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 967 FINLAND FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 968 FINLAND PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 969 FINLAND MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 970 FINLAND MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 971 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 972 FINLAND HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 973 FINLAND GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

974 FINLAND GROWTH HORMONE THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 심판 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 975 FINLAND IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 976 FINLAND ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 977 FINLAND OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 978 FINLAND ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 979 FINLAND PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 980 FINLAND SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 981 FINLAND H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 982 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 핀란드 MICRONUTRIENT SUPPLEMENTATION

TABLE 983 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 984 FINLAND BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 985 FINLAND BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

986 FINLAND 농업 & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 987 FINLAND INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 988 FINLAND OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 989 FINLAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 990 FINLAND EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 991 FINLAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 992 FINLAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 993 FINLAND GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 994 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 995 FINLAND CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 996 FINLAND SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 997 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 공정 관리 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 998 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 999 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1000 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1001 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1002 FINLAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1003 USD 기타

테이블 1004 EUROPE 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1005 EUROPE NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1006 EUROPE PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1007 EUROPE TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET의 등급, 2018-2033 (USD THOUSAND)

EUROPE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) 트레이드 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

EUROPE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1010 EUROPE ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1011 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1012 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1014 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1015 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1016 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME)에 있는 EUROPE PHARMACOLOGICAL 다른 사람의 시험) 유형에 의하여 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1017 EUROPE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1018 EUROPE GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1019 유형 1 SBS-IF (INTESTINAL FAILURE) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)에 있는 유럽 남성 호르몬의 상승

TABLE 1020 유형에 있는 EUROPE IGF-1 & ANALOGUES의 시험 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1021 EUROPE ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1022 EUROPE OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1023 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME)에 있는 EUROPE ANTI-SECRETORY THERAPY의 시험) 유형에 의하여 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1024 EUROPE PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1025 유형 1 SBS-IF에 있는 유럽 SOMATOSTATIN ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1026 EUROPE H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1027 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)의 유럽 MICRONUTRIENT SUPPLEMENTATION의 등급

TABLE 1028 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

TABLE 1029 EUROPE BILE ACID 및 ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1030 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1031 EUROPE SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1032 EUROPE INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1033 EUROPE OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1034 EUROPE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1035 EUROPE EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1036 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME)에 있는 EUROPE REGENERATIVE MEDICINE의 회전) 유형, 2018-2033 (USD THOUSAND)

TABLE 1037 EUROPE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1038 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1039 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1040 EUROPE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1041 EUROPE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1042 EUROPE 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1043 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 1044 EUROPE 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, ADMINISTRATION의 ROUTE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1045 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)과 함께 EUROPE의 정격

TABLE 1046 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1047 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

테이블 1048 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1049 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1050 USD 기타

테이블 1051 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

1052 ASIA-PACIFIC NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1053 ASIA-PACIFIC PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1054 ASIA-PACIFIC TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1055 ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1056 ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 1057 ASIA-PACIFIC ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1058 ASIA-PACIFIC TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1059 ASIA-PACIFIC FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1060 ASIA-PACIFIC PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1061 ASIA-PACIFIC MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1062 ASIA-PACIFIC MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1063 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1064 ASIA-PACIFIC HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1065 ASIA-PACIFIC GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1066 ASIA-PACIFIC GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1067 ASIA-PACIFIC IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1068 ASIA-PACIFIC ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1069 ASIA-PACIFIC OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1070 ASIA-PACIFIC ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1071 ASIA-PACIFIC PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1072 ASIA-PACIFIC SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1073 ASIA-PACIFIC H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1074 ASIA-PACIFIC MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1075 ASIA-PACIFIC ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1076 ASIA-PACIFIC BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1077 ASIA-PACIFIC BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1078 ASIA-PACIFIC SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1079 ASIA-PACIFIC INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1080 ASIA-PACIFIC OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1081 ASIA-PACIFIC INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1082 ASIA-PACIFIC EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1083 ASIA-PACIFIC REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1084 ASIA-PACIFIC MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1085 ASIA-PACIFIC GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1086 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1087 ASIA-PACIFIC CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1088 ASIA-PACIFIC SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1089 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1090 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1091 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1092 ASIA-PACIFIC INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1093 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

테이블 1094 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

테이블 1095 USD 묶음

TABLE 1096 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1097 JAPAN NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1098 JAPAN PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1099 JAPAN TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1100 JAPAN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1101 JAPAN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1102 JAPAN ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1103 JAPAN TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1104 JAPAN FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1105 JAPAN PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1106 JAPAN MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1107 JAPAN MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1108 JAPAN PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1109 JAPAN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1110 JAPAN GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1111 JAPAN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1112 JAPAN IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1113 JAPAN ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1114 JAPAN OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1115 JAPAN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1116 JAPAN PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1117 JAPAN SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)

TABLE 1118 JAPAN H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1119 JAPAN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1120 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)을 가진 SHORT BOWEL SYNDROME

TABLE 1121 JAPAN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1122 JAPAN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1123 JAPAN SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1124 JAPAN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1125 JAPAN OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1126 JAPAN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1127 JAPAN EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1128 JAPAN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1129 JAPAN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1130 JAPAN GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1131 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1132 JAPAN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1133 JAPAN SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1134 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1135 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1136 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1137 JAPAN INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1138 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER에 의해, 2018-2033 (USD THOUSAND)

TABLE 1139 JAPAN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1140 USD 리어

TABLE 1141 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1142 중국 NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1143 중국 PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1144 CHINA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1145 중국 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1146 중국 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1147 CHINA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1148 중국 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1149 중국 FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1150 유형에 있는 중국 PN 구성 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1151 유형 1 SBS-IF에 있는 중국 MACRONUTRIENTS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1152 중국 MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1153 중국 PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1154 CHINA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1155 중국 GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (미들랜드)

TABLE 1156 중국 폭 HORMONE 유형에 있는 다른 사람 1 SBS-IF (INTESTINAL 정면을 가진 포탄 SYNDROME) 무역 시장, SOMATROPIN-BASED에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1157 중국 IGF-1 & ANALOGUES 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1158 중국 ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1159 중국 OPIOID-BASED TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1160 중국 ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1161 중국 PROTON PUMP INHIBITORS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1162 중국 SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1163 중국 H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1164 중국 MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1165 중국 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1166 중국 BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1167 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1168 중국 농업 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1169 중국 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1170 중국 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1171 중국 INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1172 CHINA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1173 CHINA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1174 중국 MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1175 중국은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1176 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 시장 ATTRIBUTION에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1177 중국 핵심 SBS-IF 상표 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1178 중국 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1179 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1180 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, PATIENT 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1181 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033년의 ROUTE에 의하여, (USD THOUSAND)

TABLE 1182 중국 TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1183 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, END USER에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1184 중국 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1185 USD 기타

TABLE 1186 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 1187 SOUTH KOREA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1188 SOUTH KOREA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1189 SOUTH KOREA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1190 SOUTH KOREA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1191 SOUTH KOREA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1192 SOUTH KOREA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1193 SOUTH KOREA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1194 SOUTH KOREA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1195 SOUTH KOREA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1196 SOUTH KOREA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1197 SOUTH KOREA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1198 SOUTH KOREA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1199 SOUTH KOREA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1200 SOUTH KOREA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1201 SOUTH KOREA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1202 SOUTH KOREA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1203 SOUTH KOREA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1204 SOUTH KOREA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1205 SOUTH KOREA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1206 SOUTH KOREA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1207 SOUTH KOREA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1208 SOUTH KOREA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1209 SOUTH KOREA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1210 SOUTH KOREA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1211 SOUTH KOREA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1212 SOUTH KOREA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1213 SOUTH KOREA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1214 SOUTH KOREA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1215 SOUTH KOREA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1216 SOUTH KOREA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1217 SOUTH KOREA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1218 SOUTH KOREA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1219 SOUTH KOREA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1220 SOUTH KOREA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1221 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1222 SOUTH KOREA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1223 SOUTH KOREA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1224 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1225 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1226 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1227 SOUTH KOREA INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1228 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1229 SOUTH KOREA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1230 USD 기타

TABLE 1231 INDIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1232 INDIA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1233 INDIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1234 INDIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1235 인도 홈 파라테리아 (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1236 인도 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1237 INDIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1238 인도 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1239 INDIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1240 INDIA PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (미들랜드)

TABLE 1241 INDIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1242 INDIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1243 INDIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1244 INDIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1245 인도 GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1246 INDIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1247 인도 IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1248 INDIA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1249 INDIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1250 INDIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1251 INDIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1252 INDIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1253 INDIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1254 INDIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1255 INDIA TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1256 INDIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1257 INDIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1258 INDIA는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1259 인도 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1260 INDIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1261 INDIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1262 INDIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1263 INDIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1264 INDIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1265 INDIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1266 인디애나 타입 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1267 INDIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1268 INDIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1269 INDIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1270 INDIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1271 인도 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1272 INDIA INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1273 INDIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1274 인도 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1275 USD 리어

TABLE 1276 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 1277 SINGAPORE NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1278 SINGAPORE PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1279 SINGAPORE TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

휴대용 1280 SINGAPORE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1281 SINGAPORE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1282 SINGAPORE ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1283 SINGAPORE TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1284 SINGAPORE FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1285 SINGAPORE PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1286 SINGAPORE MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1287 SINGAPORE MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1288 SINGAPORE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1289 SINGAPORE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1290 SINGAPORE GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1291 SINGAPORE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1292 SINGAPORE IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1293 SINGAPORE ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1294 SINGAPORE OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1295 SINGAPORE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1296 SINGAPORE PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1297 SINGAPORE SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1298 SINGAPORE H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1299 SINGAPORE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1300 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1301 SINGAPORE BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1302 SINGAPORE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1303 SINGAPORE SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1304 SINGAPORE INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1305 SINGAPORE OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1306 SINGAPORE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1307 SINGAPORE EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1308 SINGAPORE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1309 SINGAPORE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1310 SINGAPORE GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1311 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 1312 SINGAPORE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1313 SINGAPORE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1314 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1315 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1316 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 1317 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1318 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1319 SINGAPORE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1320 USD 리어

TABLE 1321 타이 랜드 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1322 타이 랜드 NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1323 THAILAND PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1324 타이 랜드 OTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1325 타이 랜드 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1326 타이 랜드 HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1327 THAILAND ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1328 타이 랜드 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1329 타이 랜드 FORMULA 유형 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1330 타이 랜드 PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1331 타이 랜드 MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1332 타이 랜드 MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1333 타이 랜드 PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1334 THAILAND HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1335 THAILAND GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1336 타이 랜드 다른 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1337 타이 랜드 IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 마개 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1338 THAILAND ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1339 타이 랜드 OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1340 타이 랜드 ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1341 타이 랜드 PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1342 THAILAND SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1343 THAILAND H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1344 THAILAND MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1345 THAILAND ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1346 THAILAND BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1347 타이 랜드 바이어 타입 1 SBS-IF (INTESTINAL FAILURE) 트레이먼트 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1348 타이 랜드 농업 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1349 타이 랜드 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1350 타이 랜드 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1351 THAILAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1352 타이 랜드 EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1353 THAILAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1354 타이 랜드 MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1355 타이랜드 제네THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1356 THAILAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)

TABLE 1357 타이 랜드 CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1358 타이 랜드 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1359 타이 랜드 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1360 타이 랜드 타입 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1361 타이 랜드 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1362 THAILAND INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1363 타이 랜드 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, END USER에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1364 타이 랜드 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 배부 사슬에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1365 USD 기타

TABLE 1366 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 1367 INDONESIA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1368 INDONESIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1369 INDONESIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1370 INDONESIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1371 INDONESIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1372 INDONESIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1373 INDONESIA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1374 INDONESIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1375 INDONESIA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1376 INDONESIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1377 INDONESIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1378 INDONESIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1379 INDONESIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1380 INDONESIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1381 INDONESIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1382 INDONESIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1383 INDONESIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1384 INDONESIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1385 INDONESIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1386 INDONESIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1387 INDONESIA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1388 INDONESIA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1389 INDONESIA MICRONUTRIUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1390 INDONESIA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1391 INDONESIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1392 INDONESIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1393 INDONESIA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1394 INDONESIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1395 INDONESIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1396 INDONESIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1397 INDONESIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1398 INDONESIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1399 INDONESIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1400 INDONESIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1401 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)

TABLE 1402 INDONESIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1403 INDONESIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1404 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1405 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1406 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1407 INDONESIA INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1408 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

TABLE 1409 INDONESIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1410 USD 기타

TABLE 1411 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 1412 MALAYSIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1413 MALAYSIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1414 MALAYSIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1415 MALAYSIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1416 MALAYSIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1417 MALAYSIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1418 MALAYSIA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1419 MALAYSIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1420 MALAYSIA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1421 MALAYSIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1422 MALAYSIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1423 MALAYSIA PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1424 MALAYSIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1425 MALAYSIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1426 MALAYSIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1427 MALAYSIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1428 MALAYSIA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1429 MALAYSIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1430 MALAYSIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1431 MALAYSIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1432 MALAYSIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1433 MALAYSIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1434 MALAYSIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1435 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1436 MALAYSIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1437 MALAYSIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1438 MALAYSIA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1439 MALAYSIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1440 MALAYSIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1441 MALAYSIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1442 MALAYSIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1443 MALAYSIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1444 MALAYSIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1445 MALAYSIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1446 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1447 MALAYSIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1448 MALAYSIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1449 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1450 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1451 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1452 MALAYSIA INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (미들랜드)

TABLE 1453 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1454 MALAYSIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 배부 사슬, 2018-2033 (미들랜드)

TABLE 1455 USD 기타

TABLE 1456 PHILIPPINES TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

1457 PHILIPPINES NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1458 PHILIPPINES PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1459 PHILIPPINES TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1460 PHILIPPINES HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

1461 PHILIPPINES HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1462 PHILIPPINES ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1463 PHILIPPINES TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1464 PHILIPPINES FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1465 PHILIPPINES PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1466 PHILIPPINES MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1467 PHILIPPINES MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1468 PHILIPPINES PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1469 PHILIPPINES HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1470 PHILIPPINES GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1471 PHILIPPINES GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1472 PHILIPPINES IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1473 PHILIPPINES ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1474 PHILIPPINES OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1475 PHILIPPINES ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1476 PHILIPPINES PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1477 PHILIPPINES SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1478 필립스 H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1479 PHILIPPINES MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1480 PHILIPPINES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 심판 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1481 PHILIPPINES BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1482 PHILIPPINES BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1483 PHILIPPINES 농업 & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1484 필립 플루트 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1485 PHILIPPINES OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1486 PHILIPPINES INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1487 필립 플롭 에머 그레이싱 및 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1488 PHILIPPINES REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1489 PHILIPPINES MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1490 PHILIPPINES GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1491 PHILIPPINES TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1492 PHILIPPINES CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1493 PHILIPPINES SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1494 필립 핀 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE에 의하여, 2018-2033 (USD THOUSAND)

테이블 1495 필립 핀 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, PATIENT 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1496 PHILIPPINES TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1497 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1498 필립 핀 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

테이블 1499 필립 핀 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1500년 USD 사각

TABLE 1501 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1502 BELGIUM NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1503 BELGIUM PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1504 BELGIUM TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1505 BELGIUM HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1506 BELGIUM HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1507 BELGIUM ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1508 BELGIUM TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1509 BELGIUM FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1510 BELGIUM PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1511 BELGIUM MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1512 BELGIUM MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1513 BELGIUM PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1514 BELGIUM HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1515 BELGIUM GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1516 BELGIUM GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1517 BELGIUM IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1518 BELGIUM ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1519 BELGIUM OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1520 BELGIUM ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1521 BELGIUM PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1522 BELGIUM SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1523 BELGIUM H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1524 BELGIUM MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1525 BELGIUM ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1526 BELGIUM BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1527 BELGIUM BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1528 BELGIUM SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1529 BELGIUM INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1530 BELGIUM OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1531 BELGIUM INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1532 BELGIUM EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1533 BELGIUM REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1534 BELGIUM MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1535 BELGIUM GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1536 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1537 BELGIUM CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1538 BELGIUM SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1539 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배제 관리 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1540 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1541 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1542 BELGIUM INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1543 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1544 BELGIUM TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1545 USD 기타

TABLE 1546 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

테이블 1547 NEW ZEALAND NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1548 NEW ZEALAND PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1549 NEW ZEALAND TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1550 NEW ZEALAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1551 NEW ZEALAND HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1552 NEW ZEALAND ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1553 NEW ZEALAND TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1554 NEW ZEALAND FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1555 NEW ZEALAND PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1556 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1557 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1558 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)의 새로운 자 랜드 PHARMACOLOGICAL 기타

1559 NEW ZEALAND HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1560 NEW ZEALAND GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1561 NEW ZEALAND GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1562 NEW ZEALAND IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1563 NEW ZEALAND ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1564 NEW ZEALAND OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1565 NEW ZEALAND ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1566 NEW ZEALAND PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1567 유형 1 SBS-IF에 있는 새로운 ZEALAND SOMATOSTATIN ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1568 NEW ZEALAND H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1569 NEW ZEALAND MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1570 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1571 NEW ZEALAND BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1572 NEW ZEALAND BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1573 NEW ZEALAND SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1574 NEW ZEALAND INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1575 NEW ZEALAND OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1576 NEW ZEALAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1577 NEW ZEALAND EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1578 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)을 가진 새로운 ZEALAND REGENERATIVE MEDICINE

TABLE 1579 NEW ZEALAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1580 NEW ZEALAND GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1581 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1582 유형 1 SBS-IF에 있는 새로운 ZEALAND 핵심 SBS-IF 시장 (INTESTINAL 정면) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1583 NEW ZEALAND SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1584 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1585 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1586 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1587 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1588 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1589 NEW ZEALAND TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1590 USD 기타

TABLE 1591 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1592 HONG KONG NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1593 HONG KONG PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1594 HONG KONG TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1595 HONG KONG HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1596 HONG KONG HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1597 HONG KONG ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1598 HONG KONG 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1599 HONG KONG FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 유형 1 SBS-IF에 있는 케이블 1600 홍콩 PN 구성 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1601 HONG KONG MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1602 HONG KONG MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1603 HONG KONG PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1604 HONG KONG HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1605 홍콩 GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1606 HONG KONG GROWTH HORMONE THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1607 HONG KONG IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

케이블 1608 홍콩 ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1609 HONG KONG OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1610 홍콩 ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1611 HONG KONG PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1612 HONG KONG SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1613 홍콩 H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1614 HONG KONG MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1615 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1616 HONG KONG BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1617 HONG KONG BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1618 HONG KONG 농업 & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1619 HONG KONG INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 1620 홍콩 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1621 HONG KONG INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1622 HONG KONG EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 1623 HONG KONG REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1624 HONG KONG MICROBIOME-BASED THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1625 HONG KONG GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1626 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)에 의하여

테이블 1627 홍콩 코어 SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1628 홍콩 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1629 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (미들랜드)

케이블 1630 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

케이블 1631 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1632 HONG KONG INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1633 홍콩 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

케이블 1634 HONG KONG TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

케이블 1635 KPW

케이블 1636 타이 WAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

케이블 1637 타이완 NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1638 대만 PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

케이블 1639 타이완타륨 PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1640 타이완 홈 패런션 (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

케이블 1641 타이완 홈 패런션 (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1642 대만 표준 크기 (EN) 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1643 대만 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1644 대만 FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1645 타이완 PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1646 대만 MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1647 대만 MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1648 대만 PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1649 타이 WAN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

1650 대만 GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1651 타이완 기타 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1652 대만 IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

1653 대만 ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1654 대만 OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1655 타이완 ANTI-SECRETORY THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1656 대만 PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1657 대만 SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

케이블 1658 타이완 H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

케이블 1659 타이완 MICRONUTRIENT는 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1660 대만 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1661 TAIWAN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1662 TAIWAN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1663 타이완 특수 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

케이블 1664 타이완 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1665 타이완 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1666 타이완 INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1667 타이완 에머 그링 및 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

케이블 1668 타이완 REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1669 대만 MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1670 대만 다른 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1671 대만 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 마켓 ATTRIBUTION, 2018-2033 (USD THOUSAND)

TABLE 1672 타이완 CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1673 대만 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1674 대만 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 면세 물질 PHASE에 의해, 2018-2033 (USD THOUSAND)

케이블 1675 타이 WAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

케이블 1676 타이 WAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1677 TAIWAN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1678 대만 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

TABLE 1679 타이 WAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1680 USD 기타

ABLE 1681 아시아-패치 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) TREATMENT MARKET, TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

1682년 아시아-파시픽대학 교육지원센터(SBS-IF) 1개 SBS-IF(INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033(USD THOUSAND)

TABLE 1683년 아시아-패치 패런티(PN) IN TYPE 1 SBS-IF(SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033(USD THOUSAND)

1684 아시아-파치카타륨 패런터럴 NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, PATIENT TYPE, 2018-2033 (USD THOUSAND)

ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

1687년 아시아 패시픽 엔터럴 NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE 1 SBS-IF (SHORT BOWEL SYNDROME)에 장착 된 아시아 - PACIFIC TUBE의 1688 REST

TABLE 1689 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1690 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1691 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME를 가진) 유형 1 SBS-IF에 있는 아시아 PACIFIC MACRONUTRIUTRIENTS의 상승, 유형, 2018-2033 (USD THOUSAND)

TABLE 1692 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1693 유형 1 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, 2018-2033 (USD THOUSAND)

1694년 아시아-패시픽 해몬 & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1695 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1696 아시아 패시픽의 REST는 유형 1 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)에 의해 아시아 패시픽의 다른 사람입니다.

TABLE 1697 년 아시아 - PACIFIC IGF-1 및 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1698년 아시아 패시픽의 REST OF ASIA-PACIFIC ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1699 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1701 ASIA-PACIFIC PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1703 ASIA-PACIFIC H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1704 ASIA-PACIFIC MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1705 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1706 ASIA-PACIFIC BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

1707 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1708 ASIA-PACIFIC SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1709 아시아-파치 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1710 ASIA-PACIFIC OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1711 ASIA-PACIFIC INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1712 ASIA-PACIFIC EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1713 ASIA-PACIFIC REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1714 TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1715 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1716 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1717 ASIA-PACIFIC CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1718 ASIA-PACIFIC SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1719 아시아-패치 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (USD THOUSAND)

ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1721 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1722 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1723 아시아-패시픽 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 보웰 SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1724 아시아 패시브 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1725 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (미들랜드)

TABLE 1726 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1727 USD 기타

TABLE 1728 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 1729 SOUTH AMERICA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1730 SOUTH AMERICA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1731 SOUTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1732 SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1733 SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 1734 SOUTH AMERICA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1735 SOUTH AMERICA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1736 SOUTH AMERICA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1737 SOUTH AMERICA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1738 SOUTH AMERICA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1739 SOUTH AMERICA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1740 SOUTH AMERICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1741 SOUTH AMERICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1742 SOUTH AMERICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1743 SOUTH AMERICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1744 SOUTH AMERICA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1745 SOUTH AMERICA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1746 SOUTH AMERICA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1747 SOUTH AMERICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1748 SOUTH AMERICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1749 SOUTH AMERICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1750 SOUTH AMERICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1751 SOUTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1752 SOUTH AMERICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1753 SOUTH AMERICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1754 SOUTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1755 SOUTH AMERICA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1756 SOUTH AMERICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1757 SOUTH AMERICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1758 SOUTH AMERICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1759 SOUTH AMERICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1760 SOUTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1761 SOUTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1762 SOUTH AMERICA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1763 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1764 SOUTH AMERICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1765 SOUTH AMERICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1766 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 1767 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1768 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1769 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1770 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1771 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1772 USD 기타

TABLE 1773 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1774 BRAZIL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1775 BRAZIL PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1776 BRAZIL TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1777 BRAZIL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1778 BRAZIL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1779년 BRAZIL ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1780 BRAZIL TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1781 BRAZIL FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1782 BRAZIL PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1783년 BRAZIL MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1784 BRAZIL MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1785 BRAZIL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1786 BRAZIL HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1787 BRAZIL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1788 BRAZIL GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1789 BRAZIL IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1790 BRAZIL ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1791 BRAZIL OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1792 BRAZIL ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1793 BRAZIL PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1794 BRAZIL SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1795 BRAZIL H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1796 BRAZIL MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1797 BRAZIL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1798 BRAZIL BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1799 BRAZIL BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1800 BRAZIL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1801 BRAZIL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1802 BRAZIL OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1803 BRAZIL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1804 BRAZIL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1805 BRAZIL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1806 BRAZIL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1807 BRAZIL GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1808 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1809 BRAZIL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1810 BRAZIL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1811 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1812 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1813 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 1814 BRAZIL INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1815 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1816 BRAZIL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1817년 USD 본부

TABLE 1818 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

1819년 ARGENTINA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1820 ARGENTINA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1821 ARGENTINA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1822 ARGENTINA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

1823 ARGENTINA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1824 ARGENTINA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1825 ARGENTINA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1826 ARGENTINA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1827 ARGENTINA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1828 ARGENTINA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1829 ARGENTINA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1830 ARGENTINA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1831 ARGENTINA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1832 ARGENTINA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1833 ARGENTINA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1834 ARGENTINA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1835년 ARGENTINA ANTI-DIARRHEAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1836 ARGENTINA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1837 ARGENTINA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1838 ARGENTINA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1839 ARGENTINA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1840 ARGENTINA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1841 ARGENTINA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1842 ARGENTINA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1843 ARGENTINA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1844 ARGENTINA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1845 ARGENTINA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1846 ARGENTINA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1847 ARGENTINA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1848 ARGENTINA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1849 ARGENTINA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1850 ARGENTINA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1851 ARGENTINA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1852 ARGENTINA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1853 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 1854 ARGENTINA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1855 ARGENTINA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1856 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

테이블 1857 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1858 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 1859 ARGENTINA INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1860 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1861 ARGENTINA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1862 USD 기타

TABLE 1863 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

1864년 COLOMBIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1865 COLOMBIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1866년 COLOMBIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1867년 COLOMBIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

1868년 COLOMBIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 1869 COLOMBIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1870 COLOMBIA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 1871 COLOMBIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1872 COLOMBIA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1873 COLOMBIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1874 COLOMBIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1875 COLOMBIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1876년 COLOMBIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1877 COLOMBIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1878 COLOMBIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1879 COLOMBIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1880 COLOMBIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1881 COLOMBIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1882 COLOMBIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1883 COLOMBIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1884 COLOMBIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1885 COLOMBIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1886 COLOMBIA MICRONUTRIUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1887년 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1888 COLOMBIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1889 COLOMBIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1890년 COLOMBIA는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1891 -

TABLE 1892 COLOMBIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1893 COLOMBIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1894 COLOMBIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

1895년 COLOMBIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1896 COLOMBIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1897 COLOMBIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1898 COLOMBIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1899 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

ABLE 1900 COLOMBIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1901 COLOMBIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 1902 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

테이블 1903 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 1904 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1905 COLOMBIA는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1906 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

테이블 1907년 COLOMBIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, DISTRIBUTION CHANNEL에 의하여, 2018-2033년 (미래되는 USD)

테이블 1908 USD 묶음

TABLE 1909 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 1910 CHILE NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1911 CHILE PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1912년 CHILE TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1913 CHILE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 1914 CHILE HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

테이블 1915년 CHILE ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1916 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1917 CHILE FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1918 CHILE PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT 시장, 유형에 의해, 2018-2033 (USD THOUSAND)

테이블 1919 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME)에 있는 테이블 1920년 외투 시장, 유형에 의하여, 2018-2033 (미들랜드)

ABLE 1921 CHILE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

1922년 CHILE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1923 CHILE GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1924 CHILE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1925 CHILE IGF-1 & 유형 1 SBS-IF에 있는 ANALOGUES (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1926 CHILE ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1927 CHILE OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1928년 CHILE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1929 CHILE PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1930 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 1931년 CHILE H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1932 CHILE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 1933 CHILE ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 1934년 CHILE BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1935년 외장식 보조제는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1936 CHILE SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 1937년 외곽 INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1938 CHILE OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1939 유형 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1940 CHILE EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1941 CHILE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1942 CHILE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1943 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 1944 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

ABLE 1945 CHILE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1946 CHILE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1947년 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 배설물 PHASE에 의하여, 2018-2033 (미래되는 USD)

테이블 1948 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1949 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 1950 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, TYPE, 2018-2033 (USD THOUSAND)

테이블 1951 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 1952 CHILE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1953 USD 기타

TABLE 1954 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 1955 PERU NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1956 PERU PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1957 PERU TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1958 PERU HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1959 PERU HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 1960 PERU ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1961 PERU TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1962 PERU FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1963 PERU PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1964 PERU MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1965 PERU MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 1966 PERU PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 볼륨 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 1967 PERU HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1968 PERU GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

1969년 PERU GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 1970 PERU IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1971 PERU ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 1972 PERU OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1973 PERU ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1974 PERU PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1975 PERU SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 1976 PERU H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1977 PERU MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1978 PERU ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1979 PERU BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 1980 PERU BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1981 PERU SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1982 PERU INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1983 PERU OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1984 PERU INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1985 PERU EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 1986 PERU REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1987 PERU MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1988 PERU GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1989 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 1990 PERU CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1991 PERU SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1992 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 배율 분석, 2018-2033 (USD THOUSAND)

케이블 1993 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 1994 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 1995 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 1996 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER에 의해, 2018-2033 (USD THOUSAND)

TABLE 1997 PERU TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 1998 USD 기타

TABLE 1999 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2000 ECUADOR NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2001 ECUADOR PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2002 ECUADOR TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2003 ECUADOR HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2004 ECUADOR HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2005 ECUADOR ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2006년 ECUADOR 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2007 ECUADOR FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2008 ECUADOR PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2009년 ECUADOR MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2010 ECUADOR MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2011 ECUADOR PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2012 ECUADOR HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2013년 ECUADOR GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (미들랜드)

TABLE 2014 ECUADOR GROWTH HORMONE THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2015 ECUADOR IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2016 ECUADOR ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2017 ECUADOR OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2018 ECUADOR ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2019 ECUADOR PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2020 ECUADOR SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2021 ECUADOR H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2022 ECUADOR MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2023 ECUADOR ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2024 ECUADOR BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2025 ECUADOR BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2026 ECUADOR SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2027 ECUADOR INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2028 CUADOR OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2029 ECUADOR INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2030 ECUADOR EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2031 ECUADOR REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2032 ECUADOR MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2033 ECUADOR GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2034 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 2035년 ECUADOR CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 마개 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2036 ECUADOR SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2037 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2038 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, PATIENT 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2039 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2040 ECUADOR INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) TREATMENT 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2041 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2042 ECUADOR TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2043 USD 기타

TABLE 2044 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

케이블 2045 URUGUAY NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2046 URUGUAY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2047 URUGUAY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 2048 URUGUAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 2049 URUGUAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2050 URUGUAY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2051 URUGUAY 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2052 URUGUAY FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2053 URUGUAY PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2054 URUGUAY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2055 URUGUAY MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2056 URUGUAY PHARMACOLOGICAL THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2057 URUGUAY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2058 URUGUAY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2059 URUGUAY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2060 URUGUAY IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

케이블 2061 URUGUAY ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2062 URUGUAY OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2063 URUGUAY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2064 URUGUAY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2065 URUGUAY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2066 URUGUAY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2067 URUGUAY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2068 URUGUAY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2069 URUGUAY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2070 URUGUAY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2071 URUGUAY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2072 URUGUAY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2073 우루과이 OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2074 URUGUAY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2075 URUGUAY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2076 URUGUAY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2077 URUGUAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2078 URUGUAY GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 2079 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2080 URUGUAY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2081 URUGUAY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2082 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

케이블 2083 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2084 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2085 URUGUAY INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2086 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, END USER, 2018-2033 (USD THOUSAND)

케이블 2087 URUGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2088 USD 기타

테이블 2089 VENEZUELA 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

케이블 2090 VENEZUELA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 2091 VENEZUELA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

케이블 2092 VENEZUELA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2093 VENEZUELA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

테이블 2094 VENEZUELA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2095 VENEZUELA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 2096 VENEZUELA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2097 VENEZUELA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2098 VENEZUELA PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2099 VENEZUELA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2100 VENEZUELA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2101 VENEZUELA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2102 VENEZUELA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2103 VENEZUELA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

2104 VENEZUELA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2105 VENEZUELA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2106 VENEZUELA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2107 VENEZUELA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2108 VENEZUELA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2109 VENEZUELA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2110 VENEZUELA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2111 VENEZUELA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2112 VENEZUELA MICRONUTRIUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2113 VENEZUELA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2114 VENEZUELA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2115 VENEZUELA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2116 VENEZUELA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2117 VENEZUELA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2118 VENEZUELA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2119 VENEZUELA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2120 VENEZUELA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2121 VENEZUELA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2122 VENEZUELA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2123 VENEZUELA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 2124 VENEZUELA 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2125 VENEZUELA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2126 VENEZUELA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2127 VENEZUELA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이드 마크, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

테이블 2128 VENEZUELA 타입 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2129 VENEZUELA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2130 VENEZUELA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2131 VENEZUELA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2132 VENEZUELA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2133 USD 기타

TABLE 2134 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

2135 BOLIVIA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2136 BOLIVIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2137 BOLIVIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

2138 BOLIVIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2139 BOLIVIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2140 BOLIVIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2141 BOLIVIA 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2142 BOLIVIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2143 BOLIVIA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2144 BOLIVIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2145 BOLIVIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2146 BOLIVIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2147 BOLIVIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2148 BOLIVIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2149 BOLIVIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2150 BOLIVIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2151 BOLIVIA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2152 BOLIVIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2153 BOLIVIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2154 BOLIVIA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2155 BOLIVIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2156 BOLIVIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2157 BOLIVIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

2158 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 2159 BOLIVIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2160 BOLIVIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2161 BOLIVIA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2162 BOLIVIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2163 BOLIVIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2164 BOLIVIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2165 BOLIVIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2166 BOLIVIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2167 BOLIVIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2168 BOLIVIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2169 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, MARKET ATTRIBUTION에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2170 BOLIVIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2171 BOLIVIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2172 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 배설물 PHASE에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2173 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2174 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2175 BOLIVIA는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2176 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, END USER, 2018-2033 (USD THOUSAND)

TABLE 2177 BOLIVIA TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 분산 사슬, 2018-2033 (미들랜드)

TABLE 2178 USD 기타

TABLE 2179 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2180 PARAGUAY NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2181 PARAGUAY PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2182 PARAGUAY TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

테이블 2183 PARAGUAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2184 PARAGUAY HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2185 PARAGUAY ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2186 PARAGUAY TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2187 PARAGUAY FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2188 PARAGUAY PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2189 PARAGUAY MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2190 PARAGUAY MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2191 PARAGUAY PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2192 PARAGUAY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2193 PARAGUAY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2194 PARAGUAY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2195 PARAGUAY IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2196 PARAGUAY ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2197 PARAGUAY OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2198 PARAGUAY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2199 PARAGUAY PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2200 PARAGUAY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2201 PARAGUAY H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2202 PARAGUAY MICRONUTRIENT는 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

ABLE 2203 PARAGUAY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2204 PARAGUAY BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2205 PARAGUAY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2206 PARAGUAY SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2207 PARAGUAY INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2208 PARAGUAY OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2209 PARAGUAY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2210 PARAGUAY EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2211 PARAGUAY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2212 PARAGUAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2213 PARAGUAY GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2214 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2215 PARAGUAY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2216 PARAGUAY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2217 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

테이블 2218 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2219 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2220 PARAGUAY INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2221 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2222 PARAGUAY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2223 USD 기타

TABLE 2224 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

SOUTH AMERICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2226 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE 1 SBS-IF (SHORT BOWEL SYNDROME)에 있는 SOUTH AMERICA PARENTERAL NUTRITION (PN)

SOUTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, PATIENT TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 2230 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, 2018-2033 (USD THOUSAND)

TABLE 2231 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2233 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA MICRONUTRIENTS IN TYPE 2235 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2236 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2238 SOUTH AMERICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2239 TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

SOUTH AMERICA IGF-1 및 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME의 테이블 2240 REST, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2242 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2243 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA PROTON PUMP INHIBITORS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

SOUTH AMERICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

SOUTH AMERICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2247 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 2018-2033 (USD THOUSAND)

TABLE 2248 TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2249 REST OF SOUTH AMERICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA의 2251 REST는 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)의 TREATMENT MARKET을 준수합니다.

SOUTH AMERICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 2 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2253 SOUTH AMERICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2254 SOUTH AMERICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

SOUTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2258 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2259 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2260 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

TABLE 2261 SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2262 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2263 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2264 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2265 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2266 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2267 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2268 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2269 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, COUNTRY에 의해, 2018-2033 (USD THOUSAND)

TABLE 2270 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2271 MIDDLE EAST 및 AFRICA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2272 MIDDLE EAST 및 AFRICA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2273 MIDDLE EAST 및 AFRICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2274 MIDDLE EAST 및 AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2275 MIDDLE EAST 및 AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 2276 MIDDLE EAST 및 AFRICA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2277 MIDDLE EAST와 AFRICA 관은 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2278 MIDDLE EAST AND AFRICA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2279 MIDDLE EAST 및 AFRICA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2280 MIDDLE EAST 및 AFRICA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2281 MIDDLE EAST 및 AFRICA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2282 MIDDLE EAST 및 AFRICA 화학 물질 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2283 MIDDLE EAST AND AFRICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2284 MIDDLE EAST 및 AFRICA GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2285 MIDDLE EAST AND AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2286 MIDDLE EAST와 AFRICA IGF-1 & ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2287 MIDDLE EAST 및 AFRICA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2288 MIDDLE EAST 및 AFRICA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2289 MIDDLE EAST 및 AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2290 MIDDLE EAST 및 AFRICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2291 MIDDLE EAST 및 AFRICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2292 MIDDLE EAST 및 AFRICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2293 MIDDLE EAST 및 AFRICA MICRONUTRIENT SUPPLEMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2294 MIDDLE EAST 및 AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2295 MIDDLE EAST AND AFRICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2296 MIDDLE EAST AND AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2297 MIDDLE EAST 및 AFRICA 경음악 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2298 MIDDLE EAST 및 AFRICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2299 MIDDLE EAST 및 AFRICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2300 MIDDLE EAST 및 AFRICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2301 MIDDLE EAST 및 AFRICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2302 MIDDLE EAST 및 AFRICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2303 MIDDLE EAST 및 AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2304 MIDDLE EAST AND AFRICA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2305 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 마켓, 2018-2033 (USD THOUSAND)

TABLE 2306 MIDDLE EAST 및 AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2307 MIDDLE EAST 및 AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2308 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 공정 관리, 2018-2033 (USD THOUSAND)

TABLE 2309 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2310 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2311 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2312 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2313 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2314 USD 기타

TABLE 2315 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, 2018-2033 (USD THOUSAND)

TABLE 2316 SAUDI ARABIA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2317 SAUDI ARABIA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2318 SAUDI ARABIA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2319 SAUDI ARABIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2320 SAUDI ARABIA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 2321 SAUDI ARABIA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2322 SAUDI ARABIA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2323 SAUDI ARABIA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2324 SAUDI ARABIA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2325 SAUDI ARABIA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2326 SAUDI ARABIA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2327 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2328 SAUDI ARABIA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2329 SAUDI ARABIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2330 SAUDI ARABIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2331 SAUDI ARABIA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2332 SAUDI ARABIA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2333 SAUDI ARABIA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2334 SAUDI ARABIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2335 SAUDI ARABIA PROTON PUMP INHIBITORS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2336 SAUDI ARABIA SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2337 SAUDI ARABIA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2338 SAUDI ARABIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2339 SAUDI ARABIA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2340 SAUDI ARABIA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2341 SAUDI ARABIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2342 SAUDI ARABIA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2343 SAUDI ARABIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2344 SAUDI ARABIA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2345 SAUDI ARABIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2346 SAUDI ARABIA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2347 SAUDI ARABIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2348 SAUDI ARABIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2349 SAUDI ARABIA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2350 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2351 SAUDI ARABIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2352 SAUDI ARABIA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2353 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 2354 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2355 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2356 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2357 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2358 SAUDI ARABIA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2359 USD 기타

TABLE 2360 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 2361 SOUTH AFRICA NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2362 SOUTH AFRICA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2363 SOUTH AFRICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2364 SOUTH AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2365 SOUTH AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

TABLE 2366 SOUTH AFRICA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2367 SOUTH AFRICA TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2368 SOUTH AFRICA FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2369 SOUTH AFRICA PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2370 SOUTH AFRICA MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2371 SOUTH AFRICA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2372 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2373 SOUTH AFRICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2374 SOUTH AFRICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2375 SOUTH AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2376 SOUTH AFRICA IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2377 SOUTH AFRICA ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2378 SOUTH AFRICA OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2379 SOUTH AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2380 SOUTH AFRICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2381 SOUTH AFRICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2382 SOUTH AFRICA H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2383 SOUTH AFRICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2384 SOUTH AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2385 SOUTH AFRICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2386 SOUTH AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2387 SOUTH AFRICA SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2388 SOUTH AFRICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2389 SOUTH AFRICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2390 SOUTH AFRICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2391 SOUTH AFRICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2392 SOUTH AFRICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2393 SOUTH AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2394 SOUTH AFRICA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2395 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2396 SOUTH AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2397 SOUTH AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2398 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배제 관리 PHASE, 2018-2033 (USD THOUSAND)

TABLE 2399 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2400 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2401 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2402 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이티 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2403 SOUTH AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2404 USD 기타

TABLE 2405 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 2406 EGYPT NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2407 EGYPT PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2408 EGYPT TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2409 EGYPT HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2410 EGYPT HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2411 EGYPT ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2412 EGYPT TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2413 EGYPT FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2414 EGYPT PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2415 EGYPT MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2416 EGYPT MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2417 EGYPT PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2418 EGYPT HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2419 EGYPT GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2420 EGYPT GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2421 EGYPT IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2422 EGYPT ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2423 EGYPT OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2424 EGYPT ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2425 EGYPT PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2426 EGYPT SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2427 EGYPT H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2428 EGYPT MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2429 EGYPT ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2430 EGYPT BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2431 EGYPT BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2432 EGYPT 수력 및 INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2433 EGYPT INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2434 EGYPT OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2435 EGYPT INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2436 EGYPT EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2437 EGYPT REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2438 EGYPT MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2439 EGYPT GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2440 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2441 EGYPT CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2442 EGYPT SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2443 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 2444 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2445 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2446 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2447 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2448 EGYPT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2449 USD 기타

TABLE 2450 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2451 ISRAEL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2452 ISRAEL PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2453 ISRAEL TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2454 ISRAEL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2455 ISRAEL HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2456 ISRAEL ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2457 ISRAEL TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2458 ISRAEL FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2459 ISRAEL PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT 시장, 유형에 의해, 2018-2033 (USD THOUSAND)

TABLE 2460 ISRAEL MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2461 ISRAEL MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2462 ISRAEL PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2463 ISRAEL HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2464 ISRAEL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2465 ISRAEL GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2466 ISRAEL IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2467 ISRAEL ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2468 ISRAEL OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2469 ISRAEL ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2470 ISRAEL PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2471 ISRAEL SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2472 ISRAEL H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2473 ISRAEL MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2474 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 2475 ISRAEL BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2476 ISRAEL BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2477 ISRAEL SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2478 ISRAEL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2479 ISRAEL OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2480 ISRAEL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2481 ISRAEL EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2482 ISRAEL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2483 ISRAEL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2484 ISRAEL GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2485 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2486 ISRAEL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2487 ISRAEL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2488 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배제 관리 PHASE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2489 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2490 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2491 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2492 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2493 ISRAEL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2494 USD 기타

TABLE 2495 UNITED ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2496 UNITED ARAB EMIRATES NUTRITIONAL SUPPORT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 2497 유닛 ARAB EMIRATES PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2498 단위 ARAB EMIRATES TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2499 단위 ARAB EMIRATES HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2500 단위 ARAB EMIRATES HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT DURATION, 2018-2033 (USD THOUSAND)

테이블 2501 유닛 ARAB EMIRATES ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2502 유닛 ARAB EMIRATES TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2503는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME를 가진 유형에 있는 ARAB EMIRATES 포뮬라 유형, 2018-2033 (USD THOUSAND)

테이블 2504 단위 ARAB EMIRATES PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2505는 유형 1 SBS-IF에 있는 ARAB EMIRATES MACRONUTRIENTS (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 2506 유닛 ARAB EMIRATES MICRONUTRIENTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2507 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME)에 있는 병에 넣어지는 ARAB EMIRATES 약리학적인 다른 사람, 유형에 의하여, 2018-2033 (USD THOUSAND)

테이블 2508 유닛 아르AB EMIRATES HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2509 단위 ARAB EMIRATES GLP-2 ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2510는 유형 1 SBS-IF (INTESTINAL FAILURE) 무역 시장, SOMATROPIN-BASED, 2018-2033에 의하여 유형 1 SBS-IF (SHORT BOWEL SYNDROME)에 있는 무기물 HORMONE 다른 사람을, 평가합니다 (USD THOUSAND)

TABLE 2511 유형 1 SBS-IF에 있는 단위 ARAB EMIRATES IGF-1 & ANALOGUES (INTESTINAL FAILURE를 가진 호스 놀이쇠 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2512 UNITED ARAB EMIRATES ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2513 UNITED ARAB EMIRATES OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2514 단위 ARAB EMIRATES ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2515는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 맨 위 놀이쇠 SYNDROME를 가진 맨 위) 구조 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2516 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME)에 있는 분리되는 ARAB EMIRATES SOMATOSTATIN ANALOGUES는 유형, 2018-2033 (USD THOUSAND)에 의해 상표를 붙입니다

테이블 2517 유닛 ARAB EMIRATES H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2518 단위 ARAB EMIRATES MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2519 유형 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2520 UNITED ARAB EMIRATES BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2521 단위 ARAB EMIRATES 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2522는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME를 가진 유형 1개의 SBS-IF (SHORT BOWEL SYNDROME에 있는 엄격한 & INTERVENTIONAL TREATMENT, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2523 단위 ARAB EMIRATES INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2524는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME를 가진 유형 1개의 SBS-IF에 있는 OSTOMY & RECONSTRUCTION) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2525 UNITED ARAB EMIRATES INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2526는 유형 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME를 가진 유형 1개의 SBS-IF (SHORT BOWEL SYNDROME에 있는 EMERGING & ADVANCED THERAPIES) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2527 UNITED ARAB EMIRATES REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2528 단위 ARAB EMIRATES MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2529 UNITED ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2530 단위 ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 마켓, 2018-2033 (USD THOUSAND)

TABLE 2531 유형 1 SBS-IF에 있는 단위 핵심 SBS-IF 시장 (INTESTINAL FAILURE를 가진 마개 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2532 단위 ARAB EMIRATES SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2533 UNITED ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2534 UNITED ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2535 단위 ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2536 단위 ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2537 단위 ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2538 UNITED ARAB EMIRATES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2539 USD 기타

TABLE 2540 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MODALITY, 2018-2033 (USD THOUSAND)

TABLE 2541 KUWAIT NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2542 KUWAIT PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 항목, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2543 KUWAIT TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2544 KUWAIT HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2545 KUWAIT HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2546 KUWAIT ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2547 KUWAIT TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2548 KUWAIT FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2549 KUWAIT PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2550 KUWAIT MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2551 KUWAIT MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2552 KUWAIT PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2553 KUWAIT HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2554 KUWAIT GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2555 KUWAIT GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2556 KUWAIT IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2557 KUWAIT ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2558 KUWAIT OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2559 KUWAIT ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2560 KUWAIT PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2561 KUWAIT SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2562 KUWAIT H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2563 KUWAIT MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2564 KUWAIT ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2565 KUWAIT BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2566 KUWAIT BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2567 KUWAIT SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2568 KUWAIT INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2569 KUWAIT OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2570 KUWAIT INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2571 KUWAIT EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2572 KUWAIT REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2573 KUWAIT MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2574 KUWAIT GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2575 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 2576 KUWAIT CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2577 KUWAIT SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2578 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)

TABLE 2579 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2580 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2581 KUWAIT INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2582 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2583 KUWAIT TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2584 USD 기타

TABLE 2585 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2586 OMAN NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2587 OMAN PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2588 OMAN TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2589 OMAN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2590 OMAN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2591 OMAN ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2592 OMAN TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2593 OMAN FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2594 OMAN PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2595 OMAN MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2596 OMAN MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2597 OMAN PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2598 OMAN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2599 OMAN GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

유형 1 SBS-IF (INTESTINAL FAILURE)를 가진 마개 BOWEL SYNDROME를 가진 소매 2600 OMAN 벽 HORMONE 다른 사람, SOMATROPIN-BASED에 의하여 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2601 OMAN IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2602 OMAN ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2603 OMAN OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2604 OMAN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2605 OMAN PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2606 OMAN SOMATOSTATIN ANALOGUES TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2607 OMAN H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2608 OMAN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2609 OMAN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2610 OMAN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2611 OMAN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2612 OMAN SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2613 OMAN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2614 OMAN OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2615 OMAN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2616 OMAN EMERGING & ADVANCED THERAPIES TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

테이블 2617 OMAN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이먼트 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2618 OMAN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2619 OMAN GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2620 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2621 OMAN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2622 OMAN SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2623 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 배제 관리 PHASE에 의해, 2018-2033 (USD THOUSAND)

케이블 2624 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2625 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2626 OMAN INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

케이블 2627 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2628 OMAN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2629 USD 기타

TABLE 2630 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2631 QATAR NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2632 QATAR PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2633 QATAR TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

테이블 2634 QATAR HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2635 QATAR HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2636 QATAR ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2637 QATAR TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 모자 SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2638 QATAR FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2639 QATAR PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2640 QATAR MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2641 QATAR MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2642 QATAR PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2643 QATAR HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2644 QATAR GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2645 QATAR GROWTH HORMONE THERAPY TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2646 QATAR IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2647 QATAR ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2648 QATAR OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2649 QATAR ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2650 QATAR PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2651 QATAR SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2652 QATAR H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2653 QATAR MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2654 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)에 있는 다른 사람

TABLE 2655 QATAR BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2656 QATAR BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2657 QATAR SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2658 QATAR INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2659 QATAR OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2660 QATAR INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2661 QATAR EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2662 QATAR REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2663 QATAR MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2664 QATAR GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE에 의해, 2018-2033 (USD THOUSAND)

케이블 2665 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2666 QATAR CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2667 QATAR SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2668 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장, 공정 관리 PHASE에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2669 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE에 의해, 2018-2033 (USD THOUSAND)

TABLE 2670 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장, 2018-2033 (USD THOUSAND)

TABLE 2671 QATAR INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2672 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2673 QATAR TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2674 USD 기타

TABLE 2675 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

TABLE 2676 BAHRAIN NUTRITIONAL SUPPORT TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2677 BAHRAIN PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2678 BAHRAIN TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2679 BAHRAIN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2680 BAHRAIN HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 마켓, 2018-2033 (USD THOUSAND)

TABLE 2681 BAHRAIN ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2682 BAHRAIN TUBE FEEDING IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 호스 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2683 BAHRAIN FORMULA TYPE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2684 BAHRAIN PN COMPOSITION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2685 BAHRAIN MACRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, 으로 TYPE, 2018-2033 (USD THOUSAND)

TABLE 2686 BAHRAIN MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2687 BAHRAIN PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2688 BAHRAIN HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2689 BAHRAIN GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2690 BAHRAIN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

TABLE 2691 BAHRAIN IGF-1 & 유형에 있는 ANALOGUES 1 SBS-IF (INTESTINAL FAILURE를 가진 포탄 SYNDROME) 무역 시장, 유형에 의하여, 2018-2033 (USD THOUSAND)

TABLE 2692 BAHRAIN ANTI-DIARRHEAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2693 BAHRAIN OPIOID-BASED IN TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2694 BAHRAIN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2695 BAHRAIN PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2696 BAHRAIN SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, TYPE , 2018-2033 (USD THOUSAND)

TABLE 2697 BAHRAIN H2 RECEPTOR ANTAGONISTS TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2698 BAHRAIN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2699 BAHRAIN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2700 BAHRAIN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2701 BAHRAIN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2702 BAHRAIN SURGICAL & INTERVENTIONAL TREATMENT IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2703 BAHRAIN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2704 BAHRAIN OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 쉘 SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2705 BAHRAIN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 볼륨 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2706 BAHRAIN EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2707 BAHRAIN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2708 BAHRAIN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2709 BAHRAIN GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2710 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 BOWEL SYNDROME) 트레이티 마켓, 2018-2033 (USD THOUSAND)

TABLE 2711 BAHRAIN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 2712 BAHRAIN SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2713 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, 2018-2033 (USD THOUSAND)

케이블 2714 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2715 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 2716 BAHRAIN INTRAVENOUS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2717 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, END USER, 2018-2033 (USD THOUSAND)

TABLE 2718 BAHRAIN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, 2018-2033 (USD THOUSAND)

테이블 2719 USD 묶음

MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 짧은 BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

ABLE 2721 MIDDLE EAST 및 AFRICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2722 MIDDLE EAST 및 AFRICA PARENTERAL NUTRITION (PN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, TYPE, 2018-2033 (USD THOUSAND)

2723 MIDDLE EAST 및 AFRICA TOTAL PARENTERAL NUTRITION (TPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티 마켓, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, PATIENT TYPE, 2018-2033 (USD THOUSAND)

케이블 2725 MIDDLE EAST와 AFRICA HOME PARENTERAL NUTRITION (HPN) TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이싱 마켓, 2018-2033 (USD THOUSAND)

TABLE 2726 MIDDLE EAST 및 AFRICA ENTERAL NUTRITION (EN) TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA TUBE의 케이블 2727 REST TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2728 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA PN 구성 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

ABLE 2730 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2731 MIDDLE EAST 및 AFRICA MICRONUTRIENTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2732 MIDDLE EAST 및 AFRICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2734 MIDDLE EAST 및 AFRICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장, SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA IGF-1 및 ANALOGUES의 2736 REST TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA OPIOID-BASED의 2738 REST TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

케이블 2739 MIDDLE EAST 및 AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

TABLE 2740 MIDDLE EAST 및 AFRICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (INTESTINAL FAILURE) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

2741 MIDDLE EAST 및 AFRICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE , 2018-2033 (USD THOUSAND)

ABLE 2742 MIDDLE EAST와 AFRICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2743 MIDDLE EAST 및 AFRICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

ABLE 2744 MIDDLE EAST 및 AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA BILE ACID 및 ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA의 2747 REST는 TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이티먼트 마켓, TYPE, 2018-2033 (USD THOUSAND)에 따라 다릅니다.

ABLE 2748 MIDDLE EAST 및 AFRICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2749 MIDDLE EAST 및 AFRICA OSTOMY & RECONSTRUCTION IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 트레이드 마켓, TYPE, 2018-2033 (USD THOUSAND)

2751 MIDDLE EAST 및 AFRICA EMERGING & ADVANCED THERAPIES IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, 2018-2033 (USD THOUSAND)

2753 MIDDLE EAST 및 AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA GENE THERAPY IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2756 MIDDLE EAST 및 AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE로 BOWEL SYNDROME) 트레이드 마켓, BY TYPE, 2018-2033 (USD THOUSAND)

MIDDLE EAST 및 AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2758 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

2759 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 무역 시장, PATIENT TYPE, 2018-2033 (USD THOUSAND)

2760 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

TABLE 2761 유형 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TYPE, 2018-2033 (USD THOUSAND)

2762 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, END USER, 2018-2033 (USD THOUSAND)

2763 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE가있는 SHORT BOWEL SYNDROME) 트레이먼트 마켓, 2018-2033 (USD THOUSAND)

그림 목록

FIGURE 1 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 세그먼트

FIGURE 2 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : DATA 지구

FIGURE 3 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : DROC 분석

FIGURE 4 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 글로벌 VS REGIONAL 시장 분석

FIGURE 5 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 회사 RESEARCH 분석

FIGURE 6 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : DEMOGRAPHICS

FIGURE 7 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : DBMR 시장 위치 GRID

FIGURE 8 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : VENDOR SHARE ANALYSIS

FIGURE 9 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : MULTIVARIVATE 모델

FIGURE 10 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 제품 유형 TIMELINE CURVE

FIGURE 11 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 응용 프로그램

FIGURE 12 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : SEGMENTATION

FIGURE 13 FOUR SEGMENTS는 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET, TREATMENT MODALITY (2025)를 보완합니다.

FIGURE 14 NORTH AMERICA는 DOMINANT 및 ASIA-PACIFIC가 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 2026 년 2033 년 2033 년의 금지 시장에서 가장 빠른 속도로 시장

FIGURE 15 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 독점 요약

FIGURE 16 RISING SBS-IF PATIENT POPULATION은 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) TREATMENT MARKET에 2026 2033의 FORECAST PERIOD를 DURING합니다.

FIGURE 17 NUTRITIONAL SUPPORT THERAPY는 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME INTESTINAL FAILURE) 트레이드 마켓 2026 및 2033

FIGURE 18의 STRATEGIC 장식

FIGURE 19 SIA-PACIFIC GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME)에 대한 빠른 평가

FIGURE 20 PESTEL 분석

FIGURE 21 DROC 분석

FIGURE 22 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : TREATMENT MODALITY, 2025

FIGURE 23 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : MARKET ATTRIBUTION, 2025

FIGURE 24 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : DISEASE MANAGEMENT PHASE, 2025에 의해

FIGURE 25 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : PATIENT TYPE, 2025

FIGURE 26 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : ADMINISTRATION의 ROUTE에 의해, 2025

FIGURE 27 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : END USER, 2025

FIGURE 28 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : 분산 사슬, 2025

FIGURE 29 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : SNAPSHOT (2025)

FIGURE 30 NORTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장 : SNAPSHOT (2025)

FIGURE 31 EUROPE TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : SNAPSHOT (2025)

FIGURE 32 ASIA-PACIFIC TYPE 1 SBS-IF (INTESTINAL FAILURE를 가진 호스 BOWEL SYNDROME) 무역 시장: SNAPSHOT (2025)

FIGURE 33 SOUTH AMERICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장 : SNAPSHOT (2025)

FIGURE 34 MIDDLE EAST 및 AFRICA TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장 : SNAPSHOT (2025)

FIGURE 35 GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : COMPANY SHARE 2025 (%)

FIGURE 36 ASIA-PACIFIC GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장 : 회사 SHARE 2025 (%)

FIGURE 37 EUROPE GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 거래 시장 : COMPANY SHARE 2025 (%)

FIGURE 38 NORTH AMERICA GLOBAL TYPE 1 SBS-IF (INTESTINAL FAILURE와 함께 BOWEL SYNDROME) 무역 시장 : 회사 SHARE 2025 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

유형 1 SBS-IF (Intestinal 실패를 가진 짧은 Bowel 증후군) 처리 시장은 2025년에 USD 1.12 억에 평가되고 2033년에 USD 1.72 억에 도달하기 위하여 계획되고, 2026년에서 2033년까지 7.3%의 CAGR에 성장했습니다.
유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel 증후군) 처리 시장은 짧은 활 증후군의 증가에 의해 구동되는 2026 2033의 예측 기간 도중 7.3%의 CAGR에 성장할 것으로 예상됩니다, 진보된 영양 및 약리학적인 치료의 상승 채택, 장 재활 프로그램의 인식.
북미는 유형 1 SBS-IF (Intestinal Failure를 가진 짧은 Bowel Syndrome) 처리 시장, 2025 년 41.37%의 매출 점유율을 차지했습니다. 지역 리더십은 고급 의료 인프라, 강력한 재투자 시스템 및 전문 장 재활 및 영양 지원 서비스의 광범위한 가용성에 의해 지원됩니다.
아시아 태평양은 가장 빠르게 성장하는 지역이 될 것으로 예상되며, 2026에서 2033으로 8.0%의 CAGR을 기록합니다. 성장은 의료 인프라 개선에 의해 구동, 짧은 활 증후군의 인식과 진단 증가, 및 전문 영양 및 약리학 치료에 액세스 확장. Rising Healthcare expenditure, 증가 환자 인구, 그리고 중국과 같은 국가에서 드문 질병 관리에 투자, 인도, 일본은 더 지원 지역 시장 확장.

산업 관련 보고서

Banner
고객 후기
이미지
David Manning - Thermo Fisher Scientific 글로벌 전략 계정 디렉터
Ricky님께, 연말의 촉박한 일정에도 불구하고 귀하와 팀이 제공해 주신 훌륭한 시장 분석(LIMS 설치 기반 데이터)에 감사드립니다. Sachin과 Shraddha는 요구사항을 정확히 파악하고 실행 계획을 수립하여 신속하게 진행했습니다.
귀하, Sachin, Shraddha와의 협업은 매우 즐거웠으며 항상 신속하고 전문적이며 철저했습니다. 귀사의 노고에 깊이 감사드립니다.
이미지
시장 분석 매니저, Uriah D. Avila - Zeus Polymer Solutions
시장 보고서에 대한 지원과 상세한 분석에 감사드립니다. 결과와 맞춤화 수준에 매우 만족합니다. 앞으로도 계속 협력하기를 희망합니다.
이미지
비즈니스 개발 매니저, (비강 스프레이 제약 파트너) | Renaissance Lakewood LLC
DBMR은 글로벌 비강 스프레이 시장을 논의하는 동안 매우 적극적이고 세심하게 대응했습니다. 우리의 요구사항을 정확히 이해하고 요청한 사례를 제공했습니다. DBMR 서비스 팀은 항상 신속하게 대응해 주었습니다. 향후 필요 시 귀사의 서비스를 추천드릴 것이며, 계속해서 협력하기를 기대합니다.
이미지
비즈니스 인텔리전스 및 분석, Ipsen Biopharm Limited

중추성 조기 사춘기(CPP) 치료 보고서에 깊은 인상을 받았습니다. 팀에 큰 감사를 드립니다.

이미지
경쟁 분석가, Basler Web

정말 훌륭한 작업을 해주셨습니다. 함께 일하게 되어 기쁩니다. 앞으로도 시장 정보가 필요할 때 계속 협력하겠습니다.

이미지
마케팅 디렉터, Buhler Group

매우 좋은 경험이었습니다. 반드시 추천드리며 향후에도 다시 협력하고 싶습니다.

이미지
COO, 글로벌 약물 전달 서비스 선도 기업

DBMR은 글로벌 약물 전달 프로젝트에서 뛰어난 성과를 보여주었습니다. 간결하면서도 포괄적인 보고서와 높은 품질에 깊은 인상을 받았습니다. 본 보고서는 새로운 시장 기회를 발굴하는 데 큰 도움이 되었습니다.

이미지
마케팅 디렉터, Philips Healthcare

본 연구는 우리의 목표에 맞게 맞춤화되었으며 매우 체계적이었습니다. 다양한 글로벌 기업을 포함한 분석이 인상적이었고, DBMR 시장 포지셔닝 그리드는 매우 유용했습니다.

이미지
제품 매니저, Fujifilms

훌륭한 협업과 마지막 순간까지 지원해 주셔서 감사합니다. 이 보고서는 전략 수립에 큰 도움이 되었습니다.

이미지
투자자 관계, GE Healthcare

짧은 기간에도 불구하고 훌륭한 결과를 제공해 주셔서 감사합니다. DBMR 팀은 기대 이상이었습니다.

이미지
시장 분석가, Medincell

이번 연구 결과는 매우 인상적이었으며 새로운 시장 진입을 검토하는 데 큰 도움이 되었습니다. 훌륭한 작업에 감사드립니다.

이미지
Andrew - 글로벌 마케팅 매니저, Medtronic (미국)

이 보고서는 매우 유용했으며 사업 계획에 큰 도움이 되었습니다. 감사합니다.

이미지
Amarildo - 글로벌 전략 정렬 매니저 MasterCard

북미 로열티 관리 시장에 대한 작업은 매우 훌륭했습니다. 앞으로도 계속 협력하고 싶습니다.

이미지
Tor Hammer Green Nexus LLC

빠른 대응에 감사드립니다. 팀에도 감사 인사를 전해 주세요. 앞으로도 추가 프로젝트로 연락드리겠습니다.

이미지
Tommaso Finocchiaro 시장 정보 전문가 Nippon Gasses

짧은 일정에도 불구하고 높은 품질과 빠른 전달에 매우 만족합니다. 향후에도 Data Bridge Market Research를 우선적으로 고려하겠습니다.

이미지
Yuki Kopyl (아시아 사업 개발 부서) UENO FOOD TECHNO INDUSTRY, LTD. (일본)

자일로스 보고서는 매우 유용했습니다. 감사합니다. 앞으로도 함께 일하길 바랍니다.